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Enzyme Linked Spectroscopic Assays For Glyoxylate; The Use of Peptidylglycine
alpha-Amidating Monooxygenase for the Discovery of Novel
alpha-Amidated Hormones

Sarah Elizabeth Carpenter

ABSTRACT

Peptide hormones are responsible for cellular functions critical to the survival of an
organism. Approximately 50% of all known peptide hormones are post-translationally
modified at the C-terminus.

Enzymatic oxidative conversion of C-terminal glycine

extended peptide precursors results in an α-amidated peptide and glyoxylate.
Peptidylglycine α-amidating monooxygenase (PAM) is the single known enzyme
responsible for catalyzing this reaction. PAM is an O2, Cu(II), and Zn(II) dependent
bifunctional enzyme.

Initially, PAM hydroxylates the glycyl α-carbon followed by

dealkylation of the hydroxylated intermediate to an α-amidated product and glyoxylate.
PAM is also responsible for the conversion of glycine extended fatty acids to fatty acid
amides and glyoxylate.

PAM catalyzes the activation of all glycine-extended

prohormones including biomolecules ranging from neuro to physio-homeostatic
hormones. Identification of α-amidated hormones from a biological source has been
severely hindered by the lack of a specific assay for this distinctive class of biological
x

hormones, indicating that numerous α-amidated hormones remain undiscovered. Based
on the selective in situ chemistry of PAM, a novel and specific assay was developed for
the discovery of α-amidated hormones.

The identification of novel α-amidated

hormones will lead to an increased understanding of post-translational modifications and
will pioneer a new understanding of α-amidated hormone biosynthesis, regulation, and
bioactivity. Discovery of novel α-amidated biomolecules could also lead to their use as
pharmaceuticals as there are several currently marketed α-amidated peptide based
pharmaceuticals.

Inhibition of PAM in cell culture leads to the accumulation of glycine-extended
hormones in the conditioned medium. The medium was fractionated by chromatographic
techniques and each specific fraction was then assayed by the newly developed platform
technology for the presence of α-amidated hormones. For every α-amidated hormone
synthesized by PAM, glyoxylate is also formed. Based on this 1:1 molar ratio, several
novel spectrophotometric, fluorescent, and chemi-luminescent enzyme linked assays for
glyoxylate were developed, which when utilized on cell culture fractions proved positive
for the identification of α-amidated hormones. Each novel spectroscopic assay was
independently verified by a variety of known methodologies. Moreover the assay was
utilized to identify two known α-amidated hormones accumulated from cell culture,
which were further verified by Mass Spectral analysis.

xi

Chapter One

Peptidylglycine α-Amidating Monooxygenase (PAM)

Introduction

The Catalytic Role of Peptidylglycine α-Amidating Monooxygenase

Peptidylglycine α-amidating monooxygenase (PAM; E.C. 1.14.17.3) is the sole known
enzyme responsible for the bioconversion of inactive glycine-extended prohormones to
their bioactive α-amidated product. PAM exhibits a broad range of substrate specificity;
the enzyme can catalyze the post translational α-amidation of both glycine-extended fatty
acids, and glycine-extended peptides. Ultimately, it is the C-terminal glycyl residue
which is necessary for PAM catalysis.

PAM is a bifunctional enzyme comprised of two catalytically independent domains,
which synergistically convert a glycine extended substrate to an α-amidated product and
glyoxylate (Fig.1). Peptidylglycine α-hydroxylating monooxygenase (PHM) is an O2,
Cu(II), and ascorbate (reductant) dependent domain, which removes the pro-S hydrogen
for the hydroxylation of the glycyl α-carbon.

The second catalytic domain,

peptidylamidoglycolate lyase (PAL), is a Zn(II) dependent enzyme which dealkylates the
1

hydroxyglycine intermediate to the α-amidated product and glyoxylate. PAM is the only
known enzyme that catalyzes this unique form of post-translational modification; glycine
extended prohormones generally remain inactive prior to α-amidation.

Several

alternately spliced isoforms of PAM exist within a single organism. Often, in more
primitive organisms PAM is found as two catalytically independent domains PHM and
PAL, and in some cases only PHM is found [1].

PAM is both the rate determining, and last step in the catalytic cascade of events for the
synthesis of bioactive α-amidated hormones [2, 3] Published data has demonstrated that
the inhibition of PAM in rats, and in cultured mammalian cells leads [4, 5]to a decrease
in α-amidated peptide formation, resulting in the accumulation of the glycine-extended
precursors.

Peptide α-Amidation Reaction as Catalyzed by PAM
O
O
O-

glyoxylate
O

O

H 2O

O2

O
HN

HN

Peptide

OH

2 Cu(II)

2 Ascorbate

OH

Peptide

2 Sem id ehydroascorbate

OH

Zn(II)

Peptide

NH 2

peptide am ide

Figure 1. Peptide amidation reaction catalyzed by PAM . The bifunctional
enzyme is comprised of two separate catalytic domains: peptidylglycine αhydroxylating monooxygenase (PHM) and peptidylamidoglyco late lyase (PAL).

2

α-Amidated Peptide Hormones; Biosynthesis, Detection, and Applications

α-Amidated Peptide Hormones and their Biosynthesis

Conversion of a glycine-extended hormone to the α-amidated product is in most cases
necessary for full potency or activation of a peptide hormone [6]. Peptide hormones
containing a C-terminal α-amide functionality are widely important, found in mammals
[7, 8, 9], insects [10, 11], cnidarians [12], and plants [13]. Although, reports of αamidated peptides in plants exist, (TRH-like tripeptide, pyroGlu-Tyr-Pro amide, [13])
unpublished work from the Merkler lab indicates that a PAM-like enzyme does not exist
in plants (Carpenter and Merkler, unpublished). The absence of a PAM-like enzyme
(sequence, and catalytic similarity) suggests that plant α-amidated peptides are produced
via a PAM-independent pathway.

A catalytic cascade of sequence specific proteolytic events takes place to produce the
glycine-extended prohormone from a larger polypeptide. A C-terminal glycine extended
prohormone is generally excised from a larger peptide precursor. Peptides whose fate is
to become glycine-extended have a pair of basic amino acid flanking the internal glycine.
The collective endoproteolytic activity of substilin-like proprotein convertase (SPC), and
carboxypeptidase E (CPE) liberate the once internal glycine by removing the juxtaposed
basic residues, thereby producing the glycine-extended peptide.

3

The Rate Limiting Role of PAM

Approximately 50% of all mammalian peptide hormones have an α-amide functionality
at their C-terminus [8], in several cases conversion of the glycine-extended peptide
(PAM) to the α-amide is required for bioactivation. To further this study Merkler and
Kreil defined this by a numerical value the potency ratio [6, 9] as the bio-activity
contribution of the mature α-amidated peptide as compared to the non-amidated prohormone (see Table 1a). Evidence to support this includes the identification of several
glycine-extended peptide precursors from cell homogenates, in contrast to small
quantities of the α-amidated peptides [6, 7]. Moreover, glycine-extended adrenomedulin
from human plasma was found to be 5.4-fold higher in concentration as compared to the
mature α-amidated adrenomedulin [14]. Accumulation of the PAM substrates defines
PAM as the rate limiting step in the biosynthetic cascade of α-amidated peptide
formation. Refer to Table 1, for several examples of alternate peptide hormones, their
potency ratios, and length.

Further studies on the role of PAM in α-amidated peptide physiology, utilized a cell line
known to express PAM.

This cell line when treated with PAM anti-sense mRNA

resulted in the under-expression of PAM. PAM under-expression resulted in a peptideNH2 / Peptide-Gly ratio of ~0.3 as compared to the wild type ratio of wild ~ 1.0. These

4

results provide further evidence that PAM is involved in catalyzing the rate limiting step
in α-amidated peptide biosynthesis [15].

An Abbreviated list of α-Amidated Mammalian Peptide Hormones
C-terminus Potency Ratio a

Peptide Hormone

Length

Thyrotropin-Releasing Hormone (TRH)

3 amino acids

Pro-NH2

4,400

Calcitonin

32 amino acids

Pro-NH2

1,700

Corticotropin-Releasing Factor (CRF)

41 amino acids

Ala-NH2

1,000

Lutenizing Hormone-Releasing Factor (LHRH)

10 amino acids

Gly-NH2

1,000

Adrenomedulin

52 amino acids

Tyr-NH2

> 330

Substance P

11 amino acids

Met-NH2

100-1,000

Nueropeptide Y

36 amino acids

Tyr-NH2

>225

Secretin

27 amino acids

Val-NH2

10

Table 1. An abbreviated list of mammalian α-amidated peptide hormones, their length, Cterminus, and potency ratio [6, 9]. The potency ratio is a numerical value defined as the contribution
of the C-terminal amide to the activity of the peptide hormone. aThe potency ratio is defined as the
activity of α-amidated peptide divided by the corresponding C-terminal amino acid analog. For
example, the activity of TRH-pro-NH2 divided by the activity of TRH-pro is 4,400.
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Current Methodologies Used for the Identification of α-Amidated Hormones

Method of Tatemoto and Mutt

Tatemoto and Mutt Methodology
R1

O

R3

O

H
N

H
N

H2N

N
H
O

NH2

R2

O

R4

Novel α-amidated peptide

R1

R2

+

R3

+

R4

+

NH2
H2N

COOH

H2N

COOH

H2N

COOH

H2N

CO

Amino acid/Amino acid amide Mixture
Extraction of Amino Acid amide

Dye
Amine Labeling

R4

Dye

NH2
HN

CO

Identification of Amino Acid Amide
(Chromoatographic separation and comparison
to standards/ Mass Spec)

Figure 2. Tatemoto & Mutt Methodology. Procedure for the identification of novel α-amidated
peptides developed by Tatemoto & Mutt.
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The majority of α-amidated peptides have been isolated, to date, utilizing bioassays for
identification. The use of bioassays for the discovery of α-amidated peptides is not
uniquely specific to α-amidated peptides, and is both laborious and expensive. For
example, the α-amidated peptide neuromedulin C was isolated using a uterine contractile
assay and monitoring platelet cAMP concentrations on a set of column fractions. The use
of bioassays is not limited to α-amidated peptides only and due to these limitations other
chemical based assays have been developed.

The most successful approach for the identification of novel α-amidated hormones was
developed by Tatemoto & Mutt [16]. Tatemoto & Mutt used their procedure to isolate
and identify a number of α-amidated peptides such as galanin [17], pancreastatin [18],
PHI [19] and PYY [20]. The key to the Tatemoto-Mutt procedure is the proteolytic
fragmentation of a target peptide (Fig. 2). Proteolytic fragmentation of a target peptide
resulted in a degradation mixture of peptides, amino acids, and a single C-terminal amino
acid amide which could be chemically identified.

This degradation mixture was

subjected to dansylation, and the resultant hydrophobic dansylated-amino acids were
extracted into an organic solvent. Two-dimensional TLC was then employed to isolate
the peptides and dansylated amino acids, with a detection limit of approximately 1
nanomole. Since the development of the Tatemoto & Mutt procedure in the 1970’s,
improvements in the separation and detection of derivitized amino acid amides have been
made, [21, 22, 23, 24] with an increased detection limit in the picomole range [25].

7

Despite improvements the Tatemoto & Mutt procedure is extremely laborious and
inefficient for a variety of reasons. Incomplete proteolytic fragmentation coupled to
inefficiencies in the extraction and labeling procedures proved deleterious to assay
sensitivity as compared to model studies. This methodology has not been widely used,
and is especially non-amenable to high-throughput analysis. Consequently, Tatemoto &
Mutt have been the primary users of this technology for the discovery of novel αamidated peptides, while most others have adapted the procedure to test for and identify
the α-amidated C-terminus in an otherwise purified, bioactive peptide.

8

Method of Hill and Flannery.

Hill & Flannery Procedure for α-Amidated Peptide Discovery
I(OC(O)CF3)2
O
R
NH2

O

+ H20

O

O

R

NH2
NH

O
O

Dye

O

R

O

R

NH2
NH
O

NH2

NH

NH

Dye

I
+ CO2

OH

+ 2CF3COOH

Figure 3. Hill method for the discovery of α-amidated peptides. Outline of the technique designed
by Hill et al. for the identification of α-amidated peptides utilizing chemical dyes.

Hill and Flannery [36] developed a more chemical approach for the identification of αamidated peptides from a mixture of peptides purified from a biological source.
Acetylation of peptide free amines followed by conversion of the N-acetylamides to
amines by a Hoffman rearrangement allows for detection of the resultant amine by
ninhydrin (Fig. 3).

Amide derived amines separated into column fractions can be

correlated to the presence of a C-terminal glycine by conversion of glycine to 2thiohydantoin. This assay is based on the presumption that the C-terminal glycine and
the amide will co-elute, and that their co-elution is strongly indicative for the presence of
an α-amidated peptide. Overall, this assay is only sensitive to the millimole range, and is
completely reliant on the co-elution of two species which may or may not co-elute in
most cases. Furthermore, this assay will always be fraught with false positives for any
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Asn and Gln containing peptides. Adapting the assay for improved sensitivity by the use
of other amine dyes [25] may improve sensitivity; however it is unlikely that this
procedure could ever find a widespread use. The Hill & Flannery procedure has never
been

successfully

used

to

identify

an

α-amidated

peptide,

and

a

Web of Science search indicates that this paper has only been cited once since Feng &
Johnson [25].
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Immunological Detection of α-Amidated Peptides

A library of antibodies could theoretically be used to exploit the physiological difference
between a glycine-extended peptide and an α-amidated peptide. This approach would
necessitate the use of collection of 20 antibodies, each one specific for a particular
amino-acid amide.

The Grimmelikhuijzen group has used a similar approach by

generating an antibody against the dipeptide amide, Arg-Phe-NH2 to discover α-amidated
peptides in cnidarians [25]. This approach would require a collection of 400 antibodies
in order to test all of the possible di-peptide permutations of the 20 common amino acids.

Computer Based Analysis for α-Amidated Peptides

With the advent of the genomic database and specific peptide sequence information, it
has been suggested that the search for α-amidated peptides become a computer-based dry
technique, which could be followed by wet chemistry. Unfortunately, without a defined
model peptide sequence to search for, database searching would produce ambiguous
results. Recall, that the only defining factor for a peptide whose fate is to become
α−amidated, is the basic residues flanking the initially internal glycine. The outcome of
a computer based search on different permutations of the basic amino acid residues
would yield results entirely too non-specific and numerous.
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Therapeutic Uses of the Known α-Amidated Peptides

Table 2
Examples of Currently Marketed Peptide Hormones
Drug Name
(Company)

Compound

Delivery

Dose

Indications

Lupron
(TAP)

Nonapeptide
analog of LHRH

Subcutaneous, daily

1.0 mg daily

Advanced prostate central,
precocious puberty

DDAVP
(Sanofi-Aventis)

analog of
8-Arg vasopressin

Oral tablets

0.1 to 0.8 mg daily

Central diabetes insipidus,
primary nocturnal enuresis

Cortrosyn
(Organon)

α-(1-24)-corticotropin

i.m. or i.v. injections
or i.v. infusion

250 μg

Diagnostic agent for
adrenocortical deficiency

Sandostatin
(Novartis)

Cyclic octapeptide
analog of somatostatin

s.c or i.v. injections

50-1500 μg daily

Acromegaly, carcinoid
tumors, VIPomas

Thyrel TRH
(Ferring)

Synthetic
tripeptide

i.v. injection

500 μg

Diagnostic assessment of
thyroid function

Miacalcin
(Novartis)

Salmon calcitonin

s.c. injection

100 I.U. daily

Postmenopausal
osteoporosis, Paget’s
disease, hypercalcemia

Miacalcin Nasal
(Novartis)

Salmon calcitonin

Nasal spray

200 I.U. daily

Postmenopausal
osteoporosis

Geref
(Serono)

GHRF(1-29)-NH2

s.c. injection

30 μg/kg daily

Acthrel
(Ferring)

Ovine CRF(1-41)-NH2

i.v. injection

1.0 μg/kg single
injection

Secretin-Ferring
(Ferring)

Porcine secretin(1-27)NH2

Slow i.v. injection

1-2 CU/kg

Testing for pancreatic
function and gastrinoma

Byetta (Amylin)

Exenatide(1-39)NH2
(Exendin-4)

s.c injection

5-10 µg b.i.d.

Adjunctive therapy in
Type 2 diabetes

Fuseon (Roche)

T-20 peptide

s.c. injection

90 mg daily

Treatment of HIV-1
infection in combination
with antiretroviral agents

Symlin (Amylin)

Analog of Amylin(137)NH2

s.c. injection

15-60 µg for Type 1
and 60-120 µg
preprandial for Type
2 diabetes

Adjunct treatment for
Type 1 and Type 2
diabetes

Fortical (UpsherSmith)

Salmon calcitonin

Nasal Spray

200 I.U. daily

Postmenopausal
osteoporosis

Forteo (Lilly)

Parathyroid hormone(134)

s.c. injection

20 µg daily

Postmenopausal
osteoporosis with high risk
of fracture

Pediatric, idiopathic
growth hormone
deficiency
Differentiates pituitary and
ectopic production of
ACTH in Cushing’s
syndrome

Table 2. Examples of currently marketed peptide hormones. A summary of the currently available
therapeutic α−amidated peptide hormones, their manufacturers and pharmacological usage.
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Several α-amidated peptide hormones have already been discovered, and a few have
proven to be useful pharmaceutical therapeutics (Table. 2).

Considering the large

marketability of the known α-amidated peptides, the likelihood that undiscovered αamidated peptide hormones could lead to the development of novel diagnostics and
pharmaceuticals is of extremely high probability.

Based on the literature it is evident that some tissues known to express high levels of
PAM [27], do not produce similar quantities of known α-amidated hormones (exocrine),
and vice versa (autocrine). Autocrine cells both synthesize and utilize the machinery
necessary for their cell growth. Conversely, exocrine cells generally synthesize materials
for exportation to other cells, and acquire materials via a receptor mediated pathway.
PAM is localized in the secretory vesicles, and has been linked to both autocrine growth
factor loops [28, 29], such that PAM is both highly expressed and functional within the
same tissue, and exocrine growth loops [30, 31].

Glycine-extended hormones may

therefore be expressed in cells which do not also express PAM, and conversely cells
known to express large quantities of PAM may not co-express any glycine-extended
hormones. Thus, it is likely that several undiscovered α-amidated hormones exist both in
tissues known to express large quantities of PAM, and in tissues which do not express
large quantities of PAM. Cultured cell lines known to express large quantities of PAM,
yet not known to express many α-amidated peptides could serve as an initial source
material for the discovery of novel α-amidated hormones. It is possible that many cell
lines which do not express PAM, may express glycine-extended hormones. There are
many tissues to search for glycine-extended peptides, without a specific assay in place for
13

their discovery, the probability that several α-amidated peptides remain to be discovered
is highly likely.

A review on the literature of PAM strongly suggests that the main physiological function
of PAM is to hydroxylate (PHM) extended prohormones (glycine-extended peptides,
fatty acyl-glycines), and to further dealkylate the α-hydroxyglycyl intermediate (PAL).
Currently, no data exists to suggest an alternate physiological function of PAM, or to
provide reason for high levels of PAM in tissues not known to produce and/or utilize αamidated peptides. This fact combined with the large amounts of PAM in certain tissues
and lack of a glycine-extended hormone assay provides impetus for the assertion that
several α−amidated hormones exist which have yet to be discovered.

14

Impetus for the Design of a Novel, Broadly Applicable Assay for the Discovery of αamidated Peptide Hormones
Utilizing PAM as a General Tool for α-Amidated Hormone Discovery

From a chemical perspective there is little to differentiate an α-amidated hormone from a
non-amidated hormone. Any assay developed on the basis of an amide specific reagent
would be fraught with high backgrounds and false-positives due to the cross reactivity
with any Asn or Gln containing peptides. It is evident in the literature on α-amidated
peptides and their discovery methods, that no single methodology has proven effective as
a general and specific assay for the presence of an α-amidated peptide/hormone. The
lack of a general assay for the discovery of α-amidated peptides has left a void in the
knowledge of α-amidated peptide hormones as a whole, their biosynthesis, tissue
distribution, and physiological role. Capitalizing on the very unique role of PAM and the
stoichiometric production of glyoxylate:α-amidated peptide, identification of PAM
produced glyoxylate could lead to the identification of yet to be discovered α-amidated
hormones. Utilization of enzymatic assay systems for the detection of glyoxylate allows
for a signal specific assay, and decreases the loss of sensitivity due to high backgrounds
created by non specific interactions. As previously discussed, other α-amidated peptide
discovery methods to date have been fraught with non-specific / insufficient interactions
for α-amidated peptide detection. Quantitative analysis of PAM produced glyoxylate is
both stoichiometric for the presence of α-amidated peptides and their glycine-extended
15

prohormone precursors. Ultimately this assay has one very positive feature in that it is
non-specific for a particular class of PAM substrates, thereby increasing the application
of this assay to not only the discovery of several α-amidated peptides, but also novel αamidated fatty acid amides.
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Platform Technology Process and Design

Central Dogma for the PAM Dependent Discovery of
α-Amidated Peptides
O

Hormone N
H

O

=

Hormone NH2

=

O
O-

HO

glyoxylate

Figure 4. Central dogma for the PAM dependent discovery of α-amidated peptides. Based on the
stoichiometry for every mole hormone-Gly consumed one mole of hormone-amide and glyoxylate is
produced. Sensitive detection of glyoxylate was used to define the presence of an α-amidated hormone.

The utilization of PAM is paramount to the development and use of a robust and specific
assay for biologically generated α-amidated hormones.

Capitalizing on the unique

chemistry of PAM allows for the generation of an unequivocal route to both purify and
discover novel α-amidated hormones from a biological source. The key to designing an
assay for α-amidated peptides utilizing the unique physiological role of PAM is
glyoxylate. For every α-amidated peptide produced via PAM, a molecule of glyoxylate
results (Fig. 4). Employing glyoxylate as a signal molecule for the discovery of novel
peptides leads to the design of an assay system enriched with a specific yet general
method for detection of α-amidated peptides. As mentioned, several tissues known to
express PAM at high levels are not known to produce correspondingly high levels of αamidated peptide hormones [30, 32].
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Cell lines generated from tissues known to express high levels of PAM will serve as an
initial source material for the discovery of novel α-amidated hormones. These cells
cultured in the presence of a PAM inhibitor accumulate the glycine-extended hormone
precursors. Mains and Eipper [4, 33] demonstrated that the glycine-extended peptide
mouse joining peptide (mJP-Gly) did in fact accumulate when grown in the presence of a
PAM inhibitor. Glycine-extended precursors accumulated from cell culture when HPLC
purified [4, 34], result in a series of semi-purified fractions containing the glycineextended hormones.

Treatment of the semi-purified fractions with PAM results in

glyoxylate production only in the presence of a PAM substrate. Namely, fractions
positive for PAM produced glyoxylate, are also positive for the glycine-extended
precursor. This unique method allows for the identification of any glycine-extended
molecule permitting the identification of a broad range of novel PAM substrates. A
sensitive high-throughput assay for glyoxylate provides a signal that is independent of the
peptide (or acyl group) upstream of the terminal glycine. All fractions positive for
glyoxylate can be further analyzed for content, and the structure of novel substrates
determined by mass spectrometry.

Comparison of the cells treated with the PAM

inhibitor to non-treated cells for glyoxylate content removes the interference of any
intrinsic glyoxylate resultant of other metabolic processes.
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Development of a Series of Glyoxylate Assays; Glyoxylate as a Signal Molecule for the
Detection of α-Amidated Hormones

A series of enzyme linked glyoxylate assays have been designed and coupled to
spectrophotometric, fluorescent, and chemi-luminescent detection.

Each assay was

developed with the interest of ease of use, sensitivity, specificity, and high-through put
analysis. Based on the absolute necessity of a specific and sensitive technique, the
establishment of robust glyoxylate assays is the foundation of this novel platform
technology. Three spectrophotometric, two fluorescent, and two chemi-luminescent for a
total of seven novel enzymatic assays were created each able to detect PAM produced
glyoxylate. Each of these assays will be discussed in detail in the following chapters.
Enzymes provide a degree of selectivity far greater than that of typical chemical assays,
based on their inherent substrate specificity. The glyoxylate assays constructed for this
platform technology were designed on the premise of specificity and as a result all newly
developed assays are based on the enzymatic detection of glyoxylate. Utilizing nature’s
tools provides an unrivaled degree of sensitivity as compared to organic / chemical
methods for glyoxylate detection.
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Prior Art for the Detection of Glyoxylate; A Literature Review

The Rimini-Schryver Chemical Spectrophotometric Assay for Aldehydes

Detection of PAM produced glyoxylate is the nexus of a definitive and sensitive assay for
α-amidated peptides. Moreover, the ability to detect glyoxylate is the foundation on
which this platform technology resides. A great deal of effort has been made towards the
production of glyoxylate assays which are amenable to high throughput analysis, feasible
within the working conditions of many laboratories, and foremost sensitive detection
without ambiguity.

Methodologies utilizing chemical detection rely on the reactivity of a specific
functionality constituent of the analyte of interest. Often a chemical detection assay
design, when applied to biochemical analyses results in large background signals as a
result of the increased complexity of biochemical solutions. Detection of analytes from
biochemical samples requires analyte specific detection (enzymatic detection), as
biochemical samples are often grossly impure.

Specifically, the Rimini-Schryver

colorimetric reaction was developed as a method for the detection of formaldehyde [35].
Originally developed by Rimini the assay was developed to detect aldehydes in the
presence of phenylhydrazine and sodium hydroxide, it was later adapted by Schryver [36]
to increase sensitivity by the addition of ferriccyanide (Fe(III)) in the presence of
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hydrochloric acid (Fig. 5). The assay has in most part been utilized to detect allantoin
content in various biological fluids [37, 38], allantoin is indicative of purine metabolism
as it is the end-product of purine metabolism (Fig. 6) [38].

Rimini-Schryver Chemical Assay for Glyoxylate
HOOC

O

NH

H2N

O

HN

+

O-

H+

HN

K3Fe(CN)6

glyoxylate

glyoxylate phenylhydrazone

phenylhydrazine

Figure 5. Rimini-Schryver chemical assay for glyoxylate. The condensation reaction developed
by Rimini and adapted by Schryver, for the detection of the colorimetric condensation adduct of
glyoxylate and phenylhydrazine, glyoxylic acid phenylhydrazone respectively [35].

An excerpt of the AMP Catabolic Pathway as it Applies
to Allantoin Metabolism
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Figure 6. An excerpt of the AMP catabolic pathway as it applies to allantoin metabolism. A
portion of the AMP catabolism cascade displays the enzymatic cascade for the production of
glyoxylate from allantoin. Determination of allantoin content in blood samples was of interest in
early metabolic investigations of purine metabolism.21

The following is a list of molecules which in the presence of phenylhydrazine also
produce a hydrazone colorimetric adduct detectable at the same wavelength as the
glyoxylate: phenylhydrazone adduct: xanthine, hypoxanthine, glycerol, pyruvic acid,
malic acid, tartaric acid, alloxan, aloxantin, glycine, chloral, lactic and uric acids, and
aldehydes in general [35]. Alternately, 2,4-dinitrophenylhydrazine can also be used to
produce the condensation product glyoxylic acid 2,4-dinitrophenylhydrazone (glyoxylate
2,4-DNPH) [39]. Production of keto-acid 2,4-DNPH adducts has long since been used as
a method to characterize both aldehydes, and oximes by melting point and color.

In addition to the non-specificity, of the Rimini-Schryver method, analyses are laborious,
not very sensitive (~ 10μM), time consuming, and not completely amenable to highthroughput analysis as the colorimetric product fades quickly. Although the RiminiSchryver method has been used to detect PAM activity, its use is only amenable to the
detection of glyoxylate formed with highly purified enzyme. In addition, this assay is not
useful in the detection of PAM activity in non-pure extracts, resulting in a very limited
use of this technique.
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Determination of Glyoxylate by Capillary Electrophoresis

Calcium oxalate is the major constituent of kidney stones [40] and ~50-60% of urinary
oxalate (⎯OOC-COO⎯) is derived from the enzymatic oxidation of glyoxylate (HCOCOO⎯) [41] As a consequence of the metabolic importance and role of glyoxylate in
kidney stone formation, a number of assays have been developed for glyoxylate.
Existing assays for the determination of glyoxylate include colorimetric methods [36, 4246], fluorometric methods [47, 48], the iodometric or potentiometic titration of the
bisulfite adducts [49] and the use of capillary electrophoresis with direct UV detection
[50, 51]. Generally, these are insensitive, non-specific, or both. Capillary electrophoresis
has been the detection method of choice for the separation and quantification the organic
acids contained in urine. Capillary electrophoresis (CE) separation is based on the
movement of an analyte velocity within an electric field. The inherent velocity of an
analyte is a function of its electrophoretic mobility in relation to an applied voltage
coupled to spectrophotometric detection. Nishijima et al. [50] developed a CE separation
on a polyamide fused silica column at a constant voltage of -30kV. Urine derived
organic acids including glyoxylate elute over an eight minute period, with a detection
limit for glyoxylate of 8 - 9μM [50]. Although separation and quantification can be
achieved by the Nishijima [50] CE method, the practicality of this technique for the
quantification of glyoxylate from alternate sources is of limited value [52]. In addition to
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the limited utility a detection method based on the inherent spectrophotometric
absorption of glyoxylate itself results in a limited degree of sensitivity.
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The Fluorescent / Spectrophotometric Adduct of Glyoxylate and Resorcinol

An alternate spectrophotometric assay for glyoxylate was developed by Zarembski and
Hodgkinson in 1965 [53], based on the colored product produced by the reaction of
glyoxylate and resorcinol in the presence of an acid extract of Psuedomonas oxalaticus.
The glyoxylate : rescorcinol adduct is spectrophotometrically visible with a λmax of
490nm, and detection limit of thirteen micro-molar. In addition the colored product is
also visible by fluorescence within a pH range of 7 to 9. This procedure while not
explicitly stated in the reference is dependent upon the enzymatic activity of glyoxylate
dehydrogenase which is a metabolic product of the growth of Psuedomonas only under
high oxalate conditions. The Zarembski method is reliant on the oxalate supported
Psuedomonas extract, an extract which is extremely time and preparation intensive to
produce in any appreciable quantities.

The Zarembeski method has not found general

use, and has been cited only once since its 1965 publication.

Assay for Glyoxylate as Described by Zarembeski
HO

OH

O

+
O
O-

glyoxylate

HO

OH
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OH
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Figure 7. Assay for glyoxylate as described by Zarembeski. Proposed reaction catalyzed
in the presence of Psuedomonas oxalaticus for the formation of a glyoxylate dependent
spectrophotometricly active adduct. The proposed glyoxylate-resorcinol adduct was verified
by Vieles and Badre [54].
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Authentication the Proposed Platform Technology

Authentication of the Newly Designed Glyoxylate Assays

A variety of techniques were necessary to prove the usefulness and feasibility of all the
newly developed assays intended for the platform technology. Exigent to the use of a
glyoxylate assay as a paragon for the identification of novel α-amidated hormones was
the external standardization of each developed assay via an independent confirmed
methodology.

This served as a reference comparison for each assay in order that all

newly developed techniques could be referenced against a known control. Furthermore,
all PAM produced glyoxylate is a consequence of an enzymatic reaction with a 1:1 ratio
of glyoxylate : α-amidated peptide; measurement of produced α-amidated peptide as
compared to glyoxylate should result in a ratio of 1. All PAM produced glyoxylate
determinations were indexed against α-amidated peptide concentrations assayed via wellestablished methodologies. Once the assay was standardized against known procedures,
it was then utilized for determination of unknown glyoxylate, and PAM produced
glyoxylate.

Several techniques were utilized as standardization procedures, each to

ascertain the ratio of glyoxylate: amidated peptide. This analysis has proven invaluable
in the determination of PAM produced glyoxylate concentrations, in context to the
affirmation of newly developed techniques. Details of all authentication procedures will
be fully outlined in the following chapter.
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Authentication for the PAM Dependent Discovery of Novel α-Amidated Peptides

Prior to the utilization of the assay to discover novel hormones from a biological source,
the assay was initially used to demonstrate its ability to identify an already known αamidated hormone (mouse joining peptide, mJP-Gly). It was imperative to the utility of
the proposed assay to demonstrate this new methodology could be used to identify a
known α-amidated hormone from cell culture prior to employing the assay for the
discovery of novel α-amidated hormones. A mouse corticotropic cell line known to
produce mouse joining peptide (mJP-Gly), and accumulate mJP-Gly upon the inhibition
of PAM as outlined by Mains et. al. [4] provided the necessary data for the verification of
the newly developed platform technology. The demonstration of the platform technology
with a known glycine-extended peptide served both as an internal control and also as a
template for the empirical design of future assays for the discovery of novel α-amidated
hormones.

Delineating the assay feasibility from tissue culture to the utility of glyoxylate as a signal
for a known α-amidated peptide by mass spectrometry is discussed in detail in this work.
A comprehensive discussion of all authentication methodologies, enzymatic spectral
assays for glyoxylate, and the use of these assays towards the platform technology are
outlined in the following chapters, preceded by a thorough discussion of the newly
designed platform technology.
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Chapter Two

Glyoxylate as a Signal Molecule for the Identification of α-Amidated Peptides

Introduction

PAM Activity as a Key to the Discovery of α- Amidated Peptides

The use of glyoxylate as indicative for the presence of α-amidated hormones is truly
innovative. Development of a glyoxylate based route for α-amidated hormone detection
exploits the inherent biochemistry of their production. This was the method of choice for
a variety of fundamental reasons. Often the discovery of novel enzyme substrates is
hindered by the lack of a general non-substrate dependent assay. Glyoxylate is always a
product of PAM catalysis. This feature imparts an “analytical” quality to PAM which
had not been exploited to its full potential, prior to the development of this platform
technology. Capitalizing on this “tool-like” quality brings a novel functionality to PAM
beyond typical mechanistic biochemistry. Moreover, PAM directs both the qualitative
and quantitative discovery of α-amidated peptides via the use of glyoxylate as a signal.
Simple chemical techniques lack this unique culmination of qualities, resulting in their
definite inferiority.
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Identification of PAM Produced Glyoxylate
Manipulating the biochemical role of PAM for the discovery of α-amidated peptides
mandates the facile detection of glyoxylate as a PAM product. This feature requires that
glyoxylate assays be amenable to PAM reaction conditions. As a result, prior to the
analysis of glyoxylate, a series of sample pre-treatment procedures was necessary
pending the glyoxylate detection system. In this chapter, the development of several
spectrophotometric assays is detailed, followed by the development of more sensitive
fluorescent and chemi-luminescent assays in chapter three.

Reaction Stoichiometry of α-Amidated Peptide Production as Catalyzed
by PAM
O

Peptide

O

NH2

Peptide

+

HN

O
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OH

glycine

O

glyoxylate

O

Figure 8. Reaction Stoichiometry of α−amidated peptide production as catalyzed by PAM. The
stoichiometric production of glyoxylate : peptide-NH2 is the central dogma of the developed platform
technology.

A series of novel spectrophotometric (Chapter 2), fluorescent (Chapter 3), and chemiluminescent (Chapter 3) assays have been developed for the detection of standard
glyoxylate, PAM produced glyoxylate, and α-amidated peptides.

The differences

between standard glyoxylate detection and PAM produced glyoxylate detection is a
ramification of the necessary additional reagents used for PAM catalysis. Detection of
PAM produced glyoxylate necessitates the consideration of several factors relating to the
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tandem activity of PAM, and glyoxylate consuming enzymes.

Although glyoxylate

consuming enzymes do not need to be catalytically active in tandem with PAM, they
must be able catalytically active in the presence of the necessary PAM reagents. This is a
direct consequence of this novel platform technology, such that glycine-extended
peptides are discovered through the use of PAM and glyoxylate consuming enzymes as
analytical tools. PAM is a redox active, copper-dependent monooxygenase that relies on
the presence of a reductant for reduction of Cu(II) for catalytic turnover. Additionally,
PAM requires the presence of a radical/peroxide scavenger to protect the enzyme from
·OH radicals, and H2O2, produced as a result of the Fenton chemistry between Cu(II) and
ascorbate (reductant). Each glyoxylate assay must be designed with the presence of these
molecules in mind.

Circumvention of the tandem catalysis of PAM and glyoxylate consuming enzymes was
readily achieved. Utilizing PAM first for the production of all glyoxylate from the
glycine-extended substrates allows for inactivation of PAM after catalysis, followed by
optimization of reaction conditions for glyoxylate consuming enzymes. Inactivation of
PAM is necessary such that reaction conditions may be altered to optimize for glyoxylate
detection. It is necessary to remove PAM co-substrates, adjust pH conditions, and / or
add cofactors for the subsequent detection of glyoxylate. Ascorbate inhibits many
glyoxylate consuming enzymes and interferes with methodologies utilized to detect their
activity. Therefore it is imperative that ascorbate be removed after PAM catalysis. This
is accomplished by the oxidation of ascorbate by the enzyme ascorbate oxidase.
Likewise, in some cases addition of different buffering reagents is required to facilitate
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enzymatic detection of glyoxylate.

Manipulation of the PAM produced glyoxylate

conditions was particular to the enzyme(s) utilized for glyoxylate detection and will be
discussed as they apply to each particular glyoxylate assay.
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Introduction of Spectrophotometric Enzyme Dependent Assays for Glyoxylate

Enzyme linked spectrophotometric assays were developed around two chemistries: the
glyoxylate-dependent oxidation / reduction of NADPH / NAD+ and subsequent formazan
dye production, and the glyoxylate dependent formation of hydrogen peroxide (H2O2).

Spectrophotometric Assays for Glyoxylate
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Figure 9. Spectrophotometric assays for glyoxylate. Overview of the spectrophotometric assays
developed for the analysis of glyoxylate. (A) The malate synthase / malate dehydrogenase assay, detection
is based upon the concomitant reduction of NADH and oxidation PMS to yield a tetrazolium dye. (B) The
glycolate oxidase assay for the stoichiometric production hydrogen peroxide based on glyoxylate
consumption. (C) The glyoxylate reductase dependant glyoxylate reduction upon NADPH oxidation visible
at 340nm.
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Introduction to the Malate Synthase / Malate Dehydrogenase Glyoxylate Consuming
Enzymes

Malate synthase catalyzes the condensation of glyoxylate and acetyl-Co-A to produce
malate, and is an enzyme of the glyoxylate cycle of eubacteria, plants, and fungi [55].
The glyoxylate cycle is involved in the regeneration of three carbon molecules which
become depleted during the TCA cycle [56]. Malate synthase activity can be
spectrophotometrically measured by the release of free CoA upon condensation. Free
CoA reacts with 5’,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB / Ellman’s reagent) to
form a TNB anion (thio-bis-2-nitrobenzoate) and a CoA-TNB adduct with a λmax of
412nm and a literature extinction value of ε = 13.6 mM-1cm- 1[57].

Malate dehydrogenase is a member of the citric acid cycle; it catalyzes the last reaction of
the TCA cycle via production of oxaloacetate and NADH from malate and NAD+.
Malate dehydrogenase activity is thermodynamically regulated and plays a major role in
the regulation of NADH production.

In the forward direction the malate synthase

oxidation of malate to oxaloacetate coupled to the reduction of NAD+ to NADH, is a
highly unfavorable reaction, with a ΔGo’ = +29.7 kJmol-1
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The Glyoxylate Dependent Formation of a Formazan Dye

The concomitant oxidation of malate and reduction of NADH necessary for glyoxylate
detection is a non-spontaneous reaction of malate dehydrogenase in vitro. The large ΔGo’
value for the reduction of NAD+ by malate dehydrogenase necessitates the use of an
electron shuttling reagent for the catalytic activity in the forward direction in vitro. An
electron shuttling reagent is a catalytic redox active cycling reagent, responsible for
affecting the equilibrium of a reaction by consumption of the product. An electron
shuttling reagent is the terminal electron acceptor, which upon reduction can
auto-catalytically become re-oxidized.

This catalytic mechanism allows a single

shuttling molecule to shuttle numerous times, thereby imparting a significant effect on
the turnover of the terminal oxidant (NADH / NAD+) (Fig. 10).

Utilization of an electron shuttling reagent for NAD+ reduction by malate dehydrogenase
is a manifestation of Le Chatliers principle. For malate dehydrogenase activity, the use
of an electron shuttling reagent is essential to shift the equilibrium in favor of product
formation (NADH). This affect is a ramification of the instantaneous removal (via
oxidation) of any NADH production. In the absence of an electron shuttling reagent the
malate dehydrogenase forward reaction is catalytically incompetent as a consequence of
thermodynamic regulation.

Several molecules including, cysteine, quinones and

phenazines play the role of electron shuttling reagents in biochemical systems. A major
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prerequisite for a functional electron shuttling reagent is that it must have the correct
redox potential to be catalytically competent in a given system. Definitively, the electron
shuttling reagent redox potential (Eo’) must be a value between the Eo’ of the reductant
and the oxidant [58].

Catalytic Role of PMS
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Figure 10. Catalytic role of PMS. The electron shuttling pathway for the NADH dependent
stoichiometric reduction of MTS, the reduced MTS, formazan, is an intensely colored product visible at
λmax 490nm.
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Malate Synthase / Malate Dehydrogenase Glyoxylate Assay
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Figure 11. Malate synthase / malate dehydrogenase glyoxylate assay. The malate synthase / malate
dehydrogenase coupled assay for glyoxylate dependent upon the stoichiometric reduction of a tetrazolium
dye.
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The electron shuttling reagent chosen for the stoichiometric NADH formation and
subsequent

tetrazolium

dye

(MTS,

3-(4,5-dimethylthiazol-2-yl)-5-(3-

carboxymethoxylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) reduction was
phenazine methosulfonate (PMS) [59]. PMS is also known as pyocyanin an electron
shuttling pigment of the facultative anaerobe Psuedomonas aeruginosa [58]. PMS cycles
electrons from NADH to a tetrazolium dye via 2, 1e- processes (Fig. 10). The reduced
tetrazolium dye formazan product has a λmax of 490nm and a molar extinction coefficient
of ε = 25mM-1cm-1 [59]. This formazan dependant spectrophotometric assay is 4 fold
more sensitive than the analysis of NADH production based on extinction coefficient
alone.

Moreover, malate dehydrogenase is catalytically inactive in the absence of

phenazine methosulfonate, which drives the reaction towards concomitant glyoxylate
oxidation and NAD+ reduction (Figs.10, 11).
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Introduction to the Glyoxylate Consuming Enzyme Glycolate Oxidase

Glycolate oxidase, (E.C.1.1.3.15) is a flavin dependent, oxidoreductase enzyme found in
plants [60], protists [61], and mammals [62, 63, 64].

Enzymatic Reaction of Glycolate Oxidase
glycolate
oxidase

O

+ O2

HO

O

+ H2O2

O
O-

O-

glyoxylate

glycolate

Figure 12. Enzymatic reaction of glycolate oxidase. The oxidation of glycolate and concomitant
reduction of bimolecular oxygen as catalyzed by the enzyme glycolate oxidase.

Glycolate oxidase is a peroxisomal enzyme, which in plants is part of the photosynthetic
oxidative C2 cycle. The main function of the plant C2 cycle is for the complete oxidation
of C2 units to carbon dioxide and water. The mammalian enzyme is involved in the
production of oxalate from carbohydrates and serine [65]. Glycolate oxidase catalyzes
the oxidation of both glyoxylate and glycolate, utilizing O2 as the electron acceptor [63]
and has a pH range between 8.0 and 8.5 [66]. At pH values above 3.5 glyoxylate is found
in the hydrated gem diol form, HC(OH)2 – COOH, in aqueous solutions [67, 68]. The
glyoxylate gem diol is oxidized by glycolate oxidase to oxalate as dioxygen is reduced to
hydrogen peroxide (Fig. 12).
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The Glyoxylate Dependent Production of Hydrogen Peroxide

Several techniques exist for the spectrophotometric detection of hydrogen peroxide [69,
70, 71, 72].

The glycolate oxidase mediated conversion of glyoxylate to hydrogen

peroxide was chosen as the basis for a novel spectrophotometric glyoxylate assay. The
horse radish peroxidase (HRP), catalyzed oxidation of substrates 3-methyl-2benzothiazolinone hydrazone (MBTH), and 3-(dimethylamino)benzoic acid (DMAB), in
the presence of hydrogen peroxide produces an indamine dye adduct, 47mM-1cm-1 ≤ ε ≤
53mM-1cm-1 [73, 74] (Fig. 13).

The MBTH / DMAB / HRP assay for hydrogen peroxide detection was chosen over other
methods as a few key characteristics provided this assay with higher sensitivity, and ease
of use. Several alternate HRP substrates, (homovanillic acid, resorufin, etc) undergo
auto-oxidation at rates appreciably higher than that of the indamine dye production.
Auto-oxidation of HRP substrates leads to the generation of background values
approaching levels sufficiently large to affect the dynamic linear range of analyte
detection. Spectrophotometric detection is fundamentally limited at high concentrations
on account of light scattering due to precipitation (solubility issues at high analyte
concentration), and by incomplete percent transmission of highly colored solutions
(Abs = 2 − log % T).

Auto-oxidation becomes increasingly limiting for end-point

enzymatic assays as long incubations at 37oC are required for reaction completion.
Particularly, in the case of glycolate oxidase which has an incubation period of 40
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minutes for glyoxylate detection (Fig. 14). Collectively, these issues significantly affect
the both the limit of detection and dynamic linear range of analyte detection as compared
to the DMAB / MBTH / HRP assay where auto-oxidation is comparably much less.
Moreover, the DMAB / MBTH / HRP assay has a comparably large extinction
coefficient. A glyoxylate dependent stoichiometric assay utilizing glycolate oxidase and
the DMAB/MBTH peroxidase detection system has been developed based on this
chemistry.

H2O2 Dependent Indamine Dye Production
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Figure 13. H2O2 dependent indamine dye production. The mechanism for hydrogen peroxide detection,
based upon the HRP dependent oxidative coupling of DMAB and MBTH to produce the blue colored
indamine dye adduct.

The glycolate oxidase assay for glyoxylate based on stoichiometric hydrogen peroxide
detection is an enzyme coupled assay reliant on catalytically competent HRP. In order
for the assay to be stoichiometric (linear over a defined range) for glyoxylate, the rate of
HRP dye production must be on the order of at least 10-fold higher than glycolate oxidase
activity. Such that color formation is directly proportional to the glyoxylate dependent
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hydrogen peroxide production, and not affected by the rate of indamine dye formation.
Such an assay requires the vmax of HRP to far exceed that of the glycolate oxidase, for an
almost instantaneous color formation upon hydrogen peroxide production.

Glycolate Oxidase Based H2O2 Assay
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Figure 14. Glycolate oxidase based H2O2 assay. The glycolate oxidase assay developed for glyoxylate
detection coupled to the peroxidase indamine dye detection system.
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Introduction to the Glyoxylate Consuming Enzyme Glyoxylate Reductase

Glyoxylate Reductase (GR) is a NADPH dependant reductase, and catalyzes the
reduction of glyoxylate to glycolate with the concomitant oxidation of NADPH (or
NADH) (Fig. 15). Glyoxylate reductase was first isolated from the leaves of Spinachea
olericea by Zelitch and Gotto in 1962 [75]. Glyoxylate reductase is also found in
bacteria [76], green algae [77], protists [78], yeast [79] and humans [80]. Liver metabolic
studies on glyoxylate reductase have shown that alteration in glyoxylate reductase
activity in vivo has been linked to hyperoxaluria [81], a ramification of altered glyoxylate
and oxalate metabolism.

In plants, glyoxylate reductase is an enzyme of the

photo-respiratory cycle, Kleczkowski and Blevins defined the kinetic constants of the
spinach isozyme, as having a higher affinity for glyoxylate (KM=0.085 mM) in the
presence of NADPH, as compared to NADH (KM=1.10mM) [82].

Enzymatic Reaction of Glyoxylate Reductase
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Figure 15. Enzymatic reaction of glyoxylate reductase. Oxidation of NADPH drives the reduction of
glyoxylate to glycolate.
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Independent Verification of Glyoxylate Concentration as a Reference Standard to
Newly Developed Assays

The development of novel assays requires an independent verification of analyte
concentration. The PAM dependent cleavage of the substrate glycyl Cα−Ν bond results
in a 1:1 ratio of glyoxylate and amidated product [83, 84]. Each novel glyoxylate assay
developed herein, was compared to the production of the corresponding amide.
Independent analysis functions to both validate each glyoxylate, as well as demonstrate
the utility of each assay for the discovery of novel α-amidated peptides.

Three reference assays were used to validate glyoxylate production; (a) the PAM
catalyzed oxidation of N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and glyoxylate,
(b) the PAM catalyzed oxidation of hippurate (N-benzoylglycine) to benzamide and
glyoxylate, and (c) the base-catalyzed dealkylation of α-hydroxyglycine to benzamide
and glyoxylate (Fig. 16).

For each reference reaction, a RP-HPLC separation of substrate and amide product was
developed and used to determine the concentration of amide formed. The concentration
of the amide product was then compared to the glyoxylate concentration, as determined
using the newly developed assays.
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Reference Reactions for the Independent Analysis of the Developed
Glyoxylate Assays
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Figure 16. Reference reactions for the independent analysis of the developed glyoxylate assays. Three
reference reactions for the independent analysis of glyoxylate utilized as a standard for all newly developed
glyoxylate assays. (A) The PAM catalyzed oxidation of the dansylated tri-peptide substrate, amide product
quantified by RP-HPLC coupled to fluorescent detection. (B) The PAM catalyzed oxidation of hippurate
to benzamide and glyoxylate, benzamide product quantified by RP-HPLC coupled to spectrophotometric
detection. (C) The base catalyzed dealkylation of α-hydroxyhippurate, product quantified by RP-HPLC
separation and UV analysis.
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Materials and Methods

Materials

B. stearothermophilus malate synthase, porcine heart malate dehydrogenase, Cucurbita
ascorbate oxidase, Spinachea olericea glycolate oxidase, acetyl-CoA, MBTH, DMAB,
HRP, lactate dehydrogenase, nicotimamide adenine dinculeotide, 5’,5’-dithio-bis-(2nitrobenzoic acid) (DTNB), NADH, NADPH, FAD, FMN, ammonium sulfate,
glyoxylate, and PMS were purchased from Sigma, α-hydroxyhippuric acid was from
Aldrich, Mimetic blue was from Prometic, MTS was a gift from Dr. T. C. Owen, and
recombinant rat peptidylglycine α-amidating monooxygenase (PAM) was a gift from
Unigene Laboratories, Inc. All other reagents were of the highest quality commercially
available.

45

Methods

Malate Synthase / Malate Dehydrogenase (MS / MD Assay) Spectrophotometric Assay
for Glyoxylate

Standardization of the MS / MD Dependent Formazan Assay with NADH.

A working stock solution of 1500μM MTS / 82.5 μMPMS was prepared in water, stored
at 4˚C, and small aliquots removed as needed to reduce light and air exposure [59].
NADH production is frequently linked to tetrazolium reduction because the detection
limit for the resulting formazan is lower than that possible for the spectrophotometric
determination of NADH [85]. To verify that NADH will drive the conversion of MTS to
a formazan, MTS reduction was initiated by the addition of NADH to a solution of
100mM triethanolamine-HCl pH 7.8, 150 μM / 8.25 μM MTS/PMS, and 0-50μM NADH
to a final volume of 1mL. After a 5 min. incubation at 37 ˚C in the dark, the absorbance
at 490nm was measured using a Jasco Model V-530 UV-VIS spectrophotometer
equipped with the Spectra Analysis software package.

The small amount of MTS

reduced for the zero NADH control was subtracted from that obtained in the presence of
NADH. Reaction conditions (pH, temperature, and choice of buffer) were chosen to
minimize the pH dependent spontaneous reduction of MTS in the absence of NADH [59,
86] and the optimal pH values for malate synthase and malate dehydrogenase [87, 88].
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Standardization of the MS / MD Assay with Glyoxylate

The enzyme-coupled assay for glyoxylate was initiated by the addition of malate synthase
and malate dehydrogenase. The assay contained a standard solution of 100 mM TEA-HCl
pH 7.8, 150μM / 8.25μM MTS/PMS, 10mM MgCl2, 400μM acetyl-CoA, 500μM NAD+,
0-50μM glyoxylate, 6U/mL malate synthase, and 6U/mL malate dehydrogenase in a final
volume of 1mL. The absorbance at 490 nm was measured after 1 hr incubation at 37˚ C
in the dark. The small amount of MTS reduced for the zero glyoxylate control was
subtracted from that obtained in the presence of glyoxylate.

Measurement of the Base-Catalyzed Production of Benzamide and Glyoxylate from αHydroxyhippurate Utilizing the MS / MD Assay

Glyoxylate is a product of the base-catalyzed N-dealkylation of carbinolamides [89].
Incubation of 2.5mM α-hydroxyhippurate (C6H5-CO-NH-CH(OH)-COO⎯) in 1.0M
NaOH for 12 hr at 37˚C resulted in the conversion of α-hydroxyhippurate to benzamide
as determined by reverse-phase HPLC.

The resultant glyoxylate concentration was

determined via the enzyme-coupled assay after appropriate dilution with H2O to a final
glyoxylate concentration of ≤40μM.
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Measurement of PAM Produced Benzamide and Glyoxylate from Hippurate Utilizing
the MS / MD Assay

Hippurate (C6H5-CO-NH-CH2-COO⎯) is a PAM substrate which is amidated to produce
benzamide and glyoxylate [83, 84]. Hippurate amidation at 37˚C was initiated by the
addition of PAM (0.6 mg) to 0.5mL of 100mM MES pH 6.0, 2.0 μM Cu(NO3)2, 1.0mM
ascorbate, and 3.5mM hippurate. At 10 min intervals, a 45μL aliquot was removed and
added to 10μL of 6% (v/v) TFA to terminate the reaction.

Percent conversion of

hippurate to benzamide was determined at each time interval by C18 RP-HPLC.

Approximately 20 nanomoles of glyoxylate was added to a 0.9mL solution containing the
necessary components for the glyoxylate assay, excluding the malate synthase, malate
dehydrogenase, and MTS/PMS. Ascorbate was eliminated from all samples, prior to
glyoxylate determination, with 1 hour incubation in the presence of 2U/mL of ascorbate
oxidase at 37˚ C. Ascorbate, a co-substrate for the PAM reaction, readily reduces MTS
and must be removed prior to addition of the MTS/PMS reagent.

After ascorbate

elimination, addition of a 100μL solution of 10X concentrated malate synthase, malate
dehydrogenase, and PMS/MTS resulted in a final 1.0mL reaction at standard conditions.
The glyoxylate concentration was determined by measuring the absorbance increase at
490nm after incubation at 37˚C for 1 hr (ε 490nm = 25.6mM-1cm-1). The small amount of
MTS reduced for a control lacking hippurate was subtracted from each time point.
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Glycolate Oxidase / HRP (GO / HRP) Spectrophotometric Assay for Glyoxylate

Standardization of the Glycolate Oxidase / Horseradish Peroxidase Assay with H2O2

A standard working solution of 0.6mM MBTH, 30mM DMAB, and 50U/mL HRP was
prepared and stored under N2 in the absence of light. The working solution must be
prepared fresh daily to avoid blank values of high absorbance. The quantification of a
standardized hydrogen peroxide solution was carried out in 80mM phosphate buffer pH
7.8. The reaction was initiated by the addition of 72μL of the working solution in a final
volume of 250μL. The formation of the blue colored indamine dye was followed at
595nm. Linear regression analysis of the obtained data was analyzed against literature
regression curves for extinction coefficient analysis.
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Standardization of the Glycolate Oxidase / Horseradish Peroxidase Assay with
Glyoxylate

Following standardization of the MBTH / DMAB / HRP dependent system for the
quantification of hydrogen peroxide, the detection system was applied to the
quantification of glyoxylate production. A standard glyoxylate solution was utilized to
develop a standard curve for the detection of glycolate oxidase produced hydrogen
peroxide. All reactions were performed in 80mM phosphate buffer pH 7.8, 0.1mM FAD,
0.48U/mL glycolate oxidase, and 0 – 4μM glyoxylate at a final volume of 250μL.
Reactions were allowed to proceed for forty minutes at 37oC prior to spectrophotometric
analysis at 595nm.
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Standardization of Glycolate Oxidase / Horseradish Peroxidase Assay for PAM
Produced Glyoxylate

PAM reactions were carried out in 100mM MOPS pH 7.1 containing 10U/mL HRP,
1mM sodium ascorbate, 1 μM Cu(NO3)2, 20μM dansyl-Tyr-Val-Gly with 3μg/mL PAM,
the reaction proceeded for one hour at 37ْ C. The resultant concentration of the amidated
PAM product was measured by RP-HPLC to quantify the exact concentrations of
[dansyl-Tyr-Val-NH2] and [glyoxylate] (Chapter 3, dansyl assay procedure). Aliquots of
the PAM reaction pertaining to variable concentrations (1, 3, 5, 7, and 9μM) of
glyoxylate were taken for analysis by the MBTH / DMAB / HRP assay. Prior to analysis
of glyoxylate by the afore described assay, the PAM reaction underwent a sample pretreatment procedure to remove no reacted (non-oxidized) ascorbate.

An aliquot of

2U/mL ascorbate oxidase was added to the PAM reaction, incubated for a one hour time
period at 37oC prior to glyoxylate analysis. Analysis of PAM produced glyoxylate was
carried out under the described conditions for 40 minutes.
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Glyoxylate Reductase Spectrophotometric Assay for Glyoxylate

Purification of Glyoxylate Reductase from Spinach

Glyoxylate reductase was purified from spinach leaves by the methods of Kleczkowski
and Blevins [82]. The enzyme was partially purified by a 49 / 60 ammonium sulfate
precipitation. The enzyme was homogenized in an extraction buffer containing 40 mM
Tricine pH 7.8, 2mM MgCl2, 1mM EDTA, 1mM benzamidine, 5μM leupeptin, and
14mM β-mercaptoethanol.

The specific activity and protein concentration of the

resuspended ammonium sulfate pellet was analyzed by the method of Kleczkowski [82].
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Standardization of Glyoxylate Reductase Assay for Glyoxylate

A standard and PAM produced glyoxylate solution was utilized to develop a standard
curve for the glyoxylate reductase detection of glyoxylate. All reactions were performed
in 100mM MOPS buffer pH 7.1, 0.2mM NADPH. 0.4mg of enzyme at a final volume of
1mL. Glyoxylate dependent loss of NADPH was monitored at λ=340nm on a Jasco
Model V530 spectrophotometer equipped with a Spectral Analysis software package.
Reactions were initiated by the addition of substrate (1, 3, 5, 7, and 9μM glyoxylate) and
the ΔΑ340nm was obtained after 10 minutes at 25oC. All ΔA340nm measurements were
obtained by the NADPH dependent loss of A340nm in the presence of glyoxylate,
subtracted from the loss A340nm in the presence of NADPH without substrate.
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Standardization of Glyoxylate Reductase Assay for PAM Produced Glyoxylate

A standard solution of PAM produced glyoxylate was produced as described (chapter 2).
The solution was utilized for standard curve analysis of the glyoxylate reductase
dependent analysis of PAM produced glyoxylate.
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Independent Analysis; C18 Reverse-Phase HPLC Separations for the Quantification of
Benzamide / Glyoxylate

C18 Reverse-Phase HPLC Separation of dansyl-Tyr-Val-Gly and dansyl-Tyr-Val-NH2

HPLC assays were performed with a Hewlett-Packard 1100 liquid chromatograph
equipped with a quaternary solvent delivery system, a heated column compartment, an
auto-sampler, and an auto injector. Analytes were detected at λexcitation = 300nm, and
λemission = 380nm using an in-line Gilson model 121 fluorometer equipped with
appropriate filters.

Separations were achieved using a Keystone ODS Hypersil C18

column (100 × 4.6 mm, 5 μ particle size). Dansyl-Tyr-Val-Gly (retention time = 1.2
min), dansyl-Tyr-Val-Gly (retention time = 2.1 min) were resolved at 50 ˚C using an
isocratic mobile phase of 100mM sodium acetate pH 6.0 / acetonitrile (52/48) at flow rate
of 1.0mL/min [90]. The percent conversion of dansyl-Tyr-Val-Gly → dansyl-Tyr-ValNH2 was calculated based on peak height values obtained using a Hewlett Packard
HP3392A integrator. The ratio of nmoles/peak area for dansyl-Tyr-Val-Gly, and dansylTyr-Val-NH2 was obtained from linear standard curves generated from 0-50 nanomoles
of each. Data resulted in the ultimate determination of the quantity of PAM produced αamidated product and glyoxylate (Fig. 17).
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C18 Reverse-Phase HPLC Separation of Hippurate, α-Hydroxyhippurate, and
Benzamide.

HPLC assays were performed with a Hewlett-Packard 1100 liquid chromatograph
equipped with a quaternary solvent delivery system, a heated column compartment, an
auto sampler, and an auto injector. Analytes were detected at 254nm using an in-line
variable wavelength UV / VIS spectrophotometer. Separations were achieved using a
Keystone ODS Hypersil C18 column (100 × 4.6 mm, 5 μm particle size). Hippurate
(retention time = 3.1min), α-hydroxyhippurate (retention time = 2.9 min), and benzamide
(retention time = 5.9 min) were resolved at 50 ˚C using an isocratic mobile phase of
100mM sodium acetate pH 6.0 / acetonitrile (82/18) at flow rate of 1.1mL/min. The
percent conversion of hippurate → benzamide or α-hydroxyhippurate → benzamide was
calculated based on peak area values obtained using a Hewlett Packard HP3392A
integrator. The ratio of nmoles/peak area for hippurate, α-hydroxyhippurate, and
benzamide

was

obtained

from

linear

0-50nmoles of each (Fig. 17, & Table 3).
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Results and Discussion

Malate Synthase / Malate Dehydrogenase Spectrophotometric Assay for Glyoxylate

MS / MD Assay for Chemically and Enzymatically Produced Glyoxylate

The increase in absorbance at 490nm from the NADH-dependent reduction of MTS (at
limiting NADH) was linear with the NADH concentration and yielded an
ε490nm = 0.0282M-1cm-1 (data not shown). The value was within 10% of that reported by
Debnam & Shearer [86], 0.0256M-1cm-1. The sequential actions of malate synthase and
malate dehydrogenase convert glyoxylate and acetyl-CoA to oxaloacetate and NADH
(Fig. 9 A). PMS-dependent NADH oxidation drives the reduction of MTS to a purplecolored formazan that produces an increase in absorbance at 490nm proportional to
[glyoxylate] (Fig. 10).

The extinction coefficient derived from these data,

ε490nm = 0.0239M-1cm-1, was within 7% of the published value (Fig. 17).
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Figure 17. Glyoxylate-Dependent Oxidation of MTS. The increase in absorbance obtained using
glyoxylate (A) and that obtained by the base-catalyzed dealkylation of α-hydroxyhippurate to benzamide
and glyoxylate (B). The data points are the average of 3-10 determinations and the error bars represent the
standard deviation of the measurements.

Carbinolamides undergo base-catalyzed N-dealkylation to produce an amide and
glyoxylate [89] R-CO-NH-CH(OH)-COO⎯ + ⎯OH → R-CO-NH2 + HCO-COO⎯ + H2O
(Fig. 16 C). The N-dealkylation of α-hydroxyhippurate provided a test for the newly
developed glyoxylate assay.

Percent conversion analysis of α-hydroxyhippurate to

benzamide by HPLC served as an independent test for the [glyoxylate] values. The Ndealkylation of 2.5mM α-hydroxyhippurate with NaOH (as described in the Materials
and Methods) resulted in a solution of 0.6mM unreacted α-hydroxyhippurate, 1.9mM
benzamide, and 1.9mM glyoxylate (76% conversion) (Fig.17 B).

Analysis of this

solution using the enzyme-coupled glyoxylate assay yielded an ε 490nm = 0.0277M-1cm-1
(Fig. 17 A).
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Table 3.

Ratio of [Glyoxylate] Produced to [Benzamide] Produced by the
PAM Treatment of Hippurate
Time (min)

Glyoxylate Produced
(mM)

Benzamide
[Glyoxylate]/[Benzamide]
Produced
(mM)
40
0.69
0.58
1.2
50
0.67
0.70
0.96
60
0.71
0.80
0.89
70
0.75
0.90
0.83
80
0.77
0.98
0.79
90
1.3
1.1
1.2
100
1.3
1.2
1.1
110
1.3
1.3
1.0
Average ± standard deviation = 1.0 ± 0.16
Note. Reactions were initiated by the addition of PAM to 2.5 mM hippurate as described in the Materials
and Methods. At the indicated time, an aliquot was removed and assayed for benzamide by HPLC and
glyoxylate using the malate synthase/malate dehydrogenase/MTS/PMS system.
Table 3. Comparison of PAM Produced Glyoxylate to Benzmide Production. The ratio of PAM
produced glyoxylate as quantified by the newly developed MS/MD assay as compared to PAM produced
benzamide analyzed by RP-HPLC.

PAM-catalyzed cleavage of the glycyl Cα-N bond of glycine to form an amide and
glyoxylate requires O2 and ascorbate as co-substrates [83, 84]. Ascorbate, a common
contaminant of biological samples, reduces MTS [91] and must be eliminated in order to
use the enzyme-coupled glyoxylate assay to measure PAM activity. Ascorbate was
effectively removed by treatment of PAM produced glyoxylate-containing samples with
2U/mL ascorbate oxidase.

The PAM-catalyzed amidation of hippurate produced

glyoxylate and benzamide at a ratio of 1.0 ± 0.16 [glyoxylate] / benzamide] (Table 3),
within experimental error of the expected stoichiometry of 1:1.
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Thus, the developed malate synthase / malate dehydrogenase assay effectively quantifies
PAM produced glyoxylate.

For the MTS-derived formazan, this translates into a

detection limit of ~2μM glyoxylate (Δε490nm = 0.05-0.06).

The enzyme-coupled

glyoxylate assay can be adapted to a microtiter plate format with a final assay volume of
0.1mL providing a detection limit of ~0.2nmoles of glyoxylate.

In conclusion, an enzyme-based method that links glyoxylate oxidation to tetrazolium
reduction has been described. Tetrazolium reduction produced a colored formazan that
enabled the spectrophotometric determination of glyoxylate.

Methods to eliminate

ascorbate enabled the successful determination of glyoxylate in samples initially
contaminated with excess ascorbate. The enzyme-coupled glyoxylate assay is amenable
for use in 96-well microplate format that will increase the sensitivity of detection and
may facilitate a high throughput analysis for glyoxylate.
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Glycolate Oxidase / Horse Radish Peroxidase Linked DMAB / MBTH
Assay for Glyoxylate

Glycolate Oxidase/Horse Radish Peroxidase Linked DMAB / MBTH / HRP Detection
of H2O2

An increase in absorbance at 595nm from the H2O2 driven HRP dependent oxidative
coupling of DMAB / MBTH was linear with the H2O2 concentration and yielded an
ε595nm = 0.0456M-1cm-1 (Fig. 18). This value was within 4.20% of that reported by Ngo
& Lenhoff [73] ε595nm = 0.0476M-1cm-1 at pH 6.5, and within 16.2 % of the value
reported by [74] ε595nm = 0.0530M-1cm-1 at pH 4.5. The HRP dependent oxidative
coupling of DMAB/MBTH was essentially instantaneous.
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Linear Regression of the DMAB / MBTH / HRP Detection of H2O2
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Figure 18. Linear regression of the DMAB / MBTH / HRP detection of H2O2. Peroxide dependant
formation of an indamine dye as analyzed at an absorbance of 595nm by a Bio-Rad Model 550 micro-plate
reading spectrophotometer.
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Glycolate Oxidase Dependent DMAB / MBTH / HRP Detection of Standard Glyoxylate

Glycolate oxidase in the presence of the glyoxylate gem diol form and O2 produces a
stoichiometric quantity of H2O2 and oxalate (Fig. 9 B). Oxidation of the glyoxylate gem
diol drives the H2O2 HRP dependent oxidative coupling of MBTH and DMAB to
produce an increase in absorbance at 595nm proportional to [glyoxylate] (Fig. 13). The
extinction coefficient derived from these data, ε595nm = 0.0450M-1cm-1, was within 3.2 %
of the Ngo & Lenhoff [73] published value (Fig. 19).

Linear Regression of the DMAB / MBTH / HRP Detection of Glyoxylate
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Figure 19. Linear regression of the DMAB / MBTH / HRP detection of glyoxylate. Calibration of
glycolate oxidase activity with glyoxylate as a substrate, demonstration for the use of glycolate oxidase as
an enzyme to detect stoichiometric quantities of glyoxylate.
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Glycolate Oxidase Dependent DMAB / MBTH / HRP Detection of PAM-Produced
Glyoxylate

The PAM-catalyzed amidation of dansyl-Tyr-Val-Gly proceeded to approximately 100%
as analyzed by RP-HPLC product formation. Thus, PAM produced a stoichiometric
quantity of [glyoxylate]f = [dansyl-Tyr-Val-Gly]i for the glycolate oxidase analysis. The
glycolate oxidase assay resulted in a ratio of 1.0 ± 0.17 (ε595nmglyoxylate = 0.0450M-1cm-1 /
εglyoxylatePAM produced = 0.0375M-1cm-1), for the compared values of standard glyoxylate vs.
PAM produced glyoxylate, a value within experimental error of 1 : 1 stoichiometry
(Fig. 20).

Linear Regression of the DMAB / MBTH / HRP Detection of
PAM-Produced Glyoxylate
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Figure 20. Linear regression of the DMAB/MBTH/HRP detection of PAM-produced glyoxylate.
Stoichiometric detection of PAM produced glyoxylate generated from a glycine-extended peptide substrate.
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The developed glycolate oxidase assay effectively quantifies PAM produced glyoxylate.
For the H2O2 produced indamine, this translates into a detection limit of ~0.5μM
glyoxylate (Δε595nm = 0.05-0.06). The enzyme-coupled glyoxylate assay was adapted to a
micro-titer plate format with a final assay volume of 0.25mL providing a detection limit
of ~125 picomoles of glyoxylate.

65

Glyoxylate Reductase Dependent Assay for Glyoxylate

Glyoxylate Reductase Detection of PAM-Produced Glyoxylate

The standardized solution of PAM produced glyoxylate as analyzed by the oxidation of
NADPH resulted in a ΔAε340nm=0.0063 M-1cm-1. This ε value is within 1% of the
reported ε340nm value for NADPH of ε340nm=0.0062 M-1cm-1(Fig. 21).

Glyoxylate Reductase Determination of PAM Produced Glyoxylate
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Figure 21. Glyoxylate Reductase Determination of PAM Produced Glyoxylate.
reductase dependent assay for glyoxylate determination.
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12

The glyoxylate

In conclusion, two enzyme based systems have successfully been developed for the
stoichiometric detection of PAM produced glyoxylate.

Both assays provide novel

methodologies for the sensitive detection of glyoxylate, glycine-extended peptide, and αamidated peptides.

It is important to note that the glycolate oxidase assay is also

amenable to the sensitive spectrophotometric detection of glycolate as well. Both assays
have proven to be valid techniques for the detection of PAM activity and have provided a
framework for the design of other more sensitive novel techniques for the stoichiometric
detection of α-amidated peptides.
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Chapter Three

Fluorescent and Chemi-Luminescent Assays for Glyoxylate

Introduction

The spectrophotometric assays described in Chapter 2 are robust, stoichiometric assays
for glyoxylate and subsequently PAM activity. However, more sensitive assays for
glyoxylate are required for the development of a platform technology to discover αamidated peptides. Several methods exist for the sensitive detection of enzyme catalysis.
In particular, fluorescent and chemi-luminescent assays for hydrogen peroxide have
detection limits in the femtomole range. To take advantage of these assays, the PAMdependent production of glyoxylate must be linked to hydrogen peroxide production.
This can be accomplished utilizing two enzymes, glycolate oxidase (chapter 2, Fig. 9 B)
and glyoxal oxidase (Fig. 22). As described in this chapter, both were used for the
successful detection of femtomole levels of PAM produced glyoxylate.

Reaction Catalyzed by Glyoxal Oxidase
O

O

glyoxal oxidase
+ H2O2

HO

+ O2

HO

O-

OO

HO

glyoxylate gem diol

oxalate

Figure 22. Reaction catalyzed by glyoxal oxidase. The glyoxal oxidase dependent production of
hydrogen peroxide from glyoxylate.
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Fluorescent Assays for the Detection of Hydrogen Peroxide

Several fluorophores exist for the fluorescent determination of hydrogen peroxide
generated in solution. Fluorescence dyes for hydrogen peroxide determination have been
designed as substrates for the enzyme horseradish peroxidase. For example, horseradish
peroxidase (E.C. 1.11.1.7.) utilizes Amplex Red® as an electron donor in a
disproportionation reaction of hydrogen peroxide to water and molecular oxygen (Fig.
23). Amplex red becomes oxidized to the intensely fluorescent compound resorufin, in a
stoichiometric ratio to hydrogen peroxide consumption. Amplex red can be utilized in a
continuous assay format for enzymatic activity assays which produce stoichiometric
quantities of hydrogen peroxide. Amplex Red® has a quantum yield (Φ) at pH = 9 (Φ =
photons absorbed / photons emitted) of 0.75, rendering Amplex Red® a highly
fluorescent fluorophore [91].

Fluorescent Analysis for H2O2 Quantification
HO

O

OH

Na+
-O

N

O

O

HRP
H2 O2

H2O

N

O

Figure 23. Fluorescent analysis for H2O2 quantification. The production of the highly fluorescent dye
resorufin, is dependent upon the horseradish peroxidase oxidative catalyzed oxidation of amplex red.
Resorufin production is stoichiometric to glyoxylate consumption.
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Enhanced Sensitivity of Amplex Red Fluorometric Detection

Spectra of the Fluorophore Resorufin
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Figure 24. Spectra of the fluorophore resorufin. The Stokes shift excitation and emission spectra for
the oxidized Amplex Red (resorufin) fluorophore [84].

Resorufin fluorescence is typically measured with an excitation λ of 560nm and emission
λ of 589nm. The sensitivity of Amplex Red, like all fluorophores, can be compromised
in a biochemical assay format as a result of a high signal / noise ratio. Fluorescence is a
process allowing for greater sensitivity as result of the Stokes’ shift (Fig. 24). The
Stokes’ shift describes the distance of the red shift exhibited by a fluorophore from a
shorter excitation wavelength to the longer emissive wavelength. Quantification of the
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emission, measures an observable event from no light emission (excitation) to emission
resulting in a smaller signal / noise ratio, thereby allowing for a greater degree of
sensitivity.

Biochemical based fluorescent assay fluorescent detection can be

compromised by auto-oxidation of the fluorophore caused by enzymes and / or enzyme
cofactors and substrates. This phenomenon will be discussed as it applies to the two
enzymatic based assay systems for glyoxylate described in the results section of this
chapter.
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Fluorescent Assays for Glyoxylate

The Flavin Dependent Glyoxylate Consuming Enzyme Glycolate Oxidase

Glycolate oxidase (hydroxyacid oxidase, E.C. 1.1.3.15) is an oxidoreductase enzyme that
typically catalyzes the oxidation of a primary alcohol in the presence of O2 to a ketone
and hydrogen peroxide (chapter 2, Fig. 9 B). Glycolate oxidase is a flavoenzyme, an
enzyme that requires a flavin prosthetic group for electron transfer from donor to
acceptor (Fig. 25). Classically, glycolate oxidase has been known as a FMN (flavin
mononucleotide) dependent flavoprotein, however published data provides evidence for
the ability of this enzyme to be catalytically competent in the presence of alternate flavin
prosthetic groups, namely, FAD [93]. The flavin-binding domain of glycolate oxidase is
deeply seated within the interior of the enzyme, and tightly bound to the interior flavin
binding domain with dissociation constants of 10-8 to 10-10M [94]. Riboflavin is the
simplest of all the flavins in that it contains the basic isoalloxazine “flavin” domain and a
D-ribitol group. FMN is riboflavin with a free phosphate attached to the D-ribitol, and,
lastly, FAD is a conjugate of FMN containing an AMP moiety via a phospho-diester
bond (Fig. 25).

72

Flavins
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Figure 25. Flavins. The structure of flavin cofactors FMN, FAD, and riboflavin, glycolate oxidase
catalysis is dependent upon the presence of either FMN or FAD.
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Utilization of Glycolate Oxidase as a Fluorescent Assay for Glyoxylate.

Fluorescence assays are limited in most part by signal/noise, due to the spontaneous
oxidation (or reduction) of fluorophores resulting in significant background fluorescence.
In addition, fluorescence detection can be further compromised in biological samples by
the intrinsic fluorescence of biological molecules (peptides, proteins, etc), thus further
affecting signal/noise. In the presence of FMN, Amplex Red non-enzymatically oxidizes
to resorufin to the extent that glycolate oxidase activity cannot be measured via an HRPdependent Amplex Red assay. However, non-enzymatic oxidation of Amplex Red is
significantly reduced in the presence of FAD. FAD is a cofactor that completely supports
glycolate oxidase activity [93].

In order to link glycolate oxidase activity to an

HRP/Amplex Red based assay, the cofactor must be FAD (Fig.26).
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Amplex Red Fluorescent Detection of H2O2
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Figure 26. Amplex Red fluorescent detection of H2O2. The fluorescent Amplex Red dependent assay
system for glyoxylate, as catalyzed by glycolate oxidase, and glyoxal oxidase.
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The Lignolytic Degrading Enzyme Glyoxal Oxidase

Glyoxal oxidase (GLOX) (Fig. 20) is a basidiomycete fungal enzyme, one of the three
enzymes used in the degradation of lignin. The fungal lignin degradation pathway plays
a major role in the decomposition of detritus, an integral part of the global carbon cycle
[95].

Lignin is the second most abundant substance on the planet second only to

cellulose, and forms the “woody” tissue of plants. Collectively, lignin is comprised of
several monolignols, namely p-courmaryl, sinapyl, and coniferyl alcohols which
compromise the basic set of monomers for the lignin polymer [96]. Degradation of lignin
is imperative to the regeneration of carbon, eventually producing atmospheric CO2. The
catalytic role of glyoxal oxidase is the oxidation of aldehydes to carboxylic acids coupled
to the concomitant reduction of dioxygen to hydrogen peroxide [97]. GLOX is a copper
metalloenzyme, containing a free radical-coupled copper active site. The radical-copper
catalytic motif comprises the two-electron redox active site. More importantly, GLOX is
isolated in the reduced form. Activation of the reduced enzyme requires oxidation via
treatment with a strong oxidant such as Ir(IV) or Mo(V), or the presence of lignin
peroxidase (LiP) or horseradish peroxidase (HRP) [97, 98, 99] for catalytic activity.
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Utilization of Glyoxal Oxidase for the Quantification of Glyoxylate

Glyoxal oxidase has broad substrate specificity among simple aldehydes (table 4).
Methylglyoxal the preferred substrate has a Km = 0.64mM as compared to glyoxylic acid
Km = 2.5mM, and a kcat/KM ratio of 12.4 % the activity for glyoxylate compared to
methylglyoxal [100] (Table. 4). Moreover, GLOX has an acidic pH optimum (Fig. 27)
which when applied to the Amplex Red detection system (Fig. 26), compromises
detection limits because the reduced Φresorufin at pH 6.0 from 0.75 to 0.11, an overall 85%
Φresorufin reduction at pH 6.0.

Glyoxal Oxidase pH Profile
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Figure 27. Glyoxal oxidase pH profile. pH profile of glyoxal oxidase shown in this figure was adapted
from Kersten and Kirk [99].

GLOX functions in the detection system of glyoxylate like glycolate oxidase: the
oxidation of the glyoxylate gem diol to oxalate with the concomitant production of H2O2.
H2O2 production is coupled to Amplex Red oxidation to resorufin as catalyzed by HRP
(Fig. 26).
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Table 4.

Kinetic Constants for Alternate Aldehyde Substrates for Glyoxal
Oxidase
Substrate

K M,
mM

kcat,
s-1

kcat / KM,
M- 1 s-1

% relative
activity

Methylglyoxal

0.64

198

309,600

100

Glyoxylic acid

2.5

96

38,200

12

Glycoaldehyde

8.3

208

25,000

8.1

Acetaldehyde

8.3

148

17,800

5.7

Formaldehyde

23

254

11,000

3.6

Glyoxal

12

118

10,400

3.3

Dihydroxyacetone

38

188

5,000

1.6

DL-Glyceraldehyde

42

148

3,600

1.1

Table 4. Kinetic constants for several aldehyde substrates of glyoxal oxidase. Figure adapted from
Kersten (1990) PNAS. Vol. 87 pp. 2936-2940 [97].

GLOX is isolated in the catalytically inactive, reduced form requiring the presence of an
oxidant for catalysis. However, the use of strong oxidants must be avoided as this results
in the spontaneous oxidation of Amplex Red. Thus, HRP has a dual role in this detection
system as it both activates the reduced glyoxal oxidase, and converts Amplex Red to
resorufin

via

a

stoichiometric

reaction
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with

H2O2

(Fig.

25).

Chemi-luminescent Assays for Hydrogen Peroxide

Chemi-luminescence is a similar process to that of fluorescence however excitation to the
excited state is dependent upon a chemical reaction rather than incident light (λex i.e.
fluorescence) (Fig. 28).

A Jablonski Diagram

Figure 28. A Jablonski diagram. Display of the different types of emission from an electronically
excited state to the ground state. Blue describes absorption, green fluorescence, and red phosphorescence.

Fluorescence and chemi-luminescence, undergo excitation, internal conversion, followed
by an observable emission. Internal conversion is a non-photo-emissive transition of
electrons between two states of the same spin number (Fig. 28), and relates to the
quantum yield of a fluorophore (Φ). Phosphorescence also undergoes a non-emissive
transition, however initially it is between two different spin states. This type of nonemissive transfer is described as intersystem crossing and is followed by internal
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conversion. Chemi-luminescence has been utilized for biochemical applications much
like fluorescence due to its enhanced sensitivity.

Luminol in the presence of an oxidative (1 or 2 e- oxidant) metal catalyst such as Mn (II)
[102], Cu(phen)32+ [103], HRP; (Fe(III)) [104,105,106,107,108,109], K4Fe(CN)6•3H2O;
(Fe(III)) [110], and Co(II) [109] and hydrogen peroxide, becomes chemically excited to a
triplet state (Fig. 29). Excitation is followed by internal conversion to a singlet state, and
lastly photo-emission. The amount of luminol photo-emission is proportional to the
concentration of hydrogen peroxide present. Luminol prior to becoming excited must be
in the doubly de-ionized form requiring that luminol chemi-luminescence be carried out
in a basic environment. Of all possible metal oxidants it was found that use of HRP
resulted in the greatest light emission by luminol [109, 106].
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Mechanism of Luminol Chemi-luminescence
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Figure 29. Mechanism of luminol chemi-luminescence. Initially, luminol is oxidized by a metal catalyst,
the oxidized luminol then reacts with hydrogen peroxide to produce the excited aminopthalate anion. The
amino-phthalate undergoes relaxation emitting blue light with a wavelength maximum at 425 nm. The
amount of light given off by the excited amino-phthalate is proportional to the concentration of hydrogen
peroxide consumed.
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Materials and Methods

Materials

Amplex red, resorufin, and luminol were purchased from Molecular Probes, (Eugene,
OR); glycolate oxidase, HRP, FMN, FAD, MES, sodium glycolate, N-dansyl-Tyr-ValGly, were purchased from Sigma-Aldrich; recombinant rat PAM was a gift from Unigene
Labs, Inc. (Fairfield, NJ); and glyoxal oxidase (source: Phanerochaete chryosporium)
was a gift from Dr. James Whittaker (OGI School of Science and Engineering, Oregon
Health and Science University, Beaverton, OR). Black flat-bottom, and U-shaped well
plates were purchased from Corning. All other reagents were of the highest quality
commercially available.
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Methods

Standardization of the Fluorophore Resorufin

A standard solution of resorufin was initially used to standardize the micro-plate
fluorometer for resorufin fluorescence. Concentrations ranging from 30nM to 9 μM of
were analyzed for fluorescent response at λex = 530nm and λem = 584nm to generate a
resorufin standard curve. Samples were analyzed in black U-shaped microplates, in a
Fluoroskan II microplate reading fluorometer equipped with the MTX software analysis
package.

Standardization of H2O2 Produced Fluorescence

A standard hydrogen peroxide solution was utilized for the preparation of a hydrogen
peroxide standard curve for resorufin production. Concentrations ranging from 30nM to
9μM peroxide were analyzed in a solution containing, HRP (1U/mL) and 50μM Amplex
Red in 50mM phosphate buffer pH 6.0, and pH 8.0.
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Glyoxal Oxidase (GLOX ) Fluorescent Assay for Glyoxylate

Standardization of the Fluorescent GLOX Assay with Standard Methyl Glyoxal and
Glyoxylate.

The GLOX assay consisted of a standard solution of 50 mM sodium phosphate pH 6.0,
50μM Amplex red, HRP (1U/mL), and either 0.03 – 2.3μM methyl glyoxal or 0.3 – 1.7
μM glyoxylate. The reaction was initiated by the addition of GLOX (final concentration
= 0.4mg/mL) and fluorescence was determined after 1 hour at 37oC in the dark for the
glyoxylate substrate and after a 30 min 37oC incubation for methyl glyoxal (λex = 530nm
and λem = 584nm). The fluorescence produced from Amplex red oxidation in the absence
of glyoxylate or methyl glyoxal was subtracted from that obtained in the presence of
glyoxylate/methyl glyoxal.
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Standardization of the Fluorescent Glyoxal Oxidase Assay for PAM Produced
Glyoxylate

Glyoxylate production was initiated by the addition of PAM (15U/L) to a solution
containing 40mM MES / NaOH pH 6.0, 10U/mL HRP, 1.0mM catechol, 0.5μM
Cu(SO4), 20μM dansyl-Tyr-Val-Gly, the reaction proceeded for one hour at37oC. It is
necessary to note that catechol was used as the reductant to support PAM catalysis, as the
Fenton chemistry produced by ascorbate in the presence of copper (generation of ·OH,
and H2O2) resulted in the complete auto-oxidation of Amplex Red. The complete PAM
dependent conversion of 20μM N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and
glyoxylate was verified by RP-HPLC to quantify the exact concentrations of [N-dansylTyr-Val-NH2] and [glyoxylate] (100% conversion, 20μM N-dansyl-Tyr-Val-NH2 and
glyoxylate).

Aliquots of the PAM produced glyoxylate pertaining to variable

concentrations (0.3, 0.7, 1.6, and 2.3μM) were utilized for analysis by the GLOX assay.
Aliquots of glyoxylate were added to a solution of 50mM sodium phosphate pH 6.0,
50μM Amplex red, at HRP (1U/mL) and a final concentration of 0.4mg/mL GLOX. All
samples were incubated at 37oC for one hour (as described chapter 3).
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Glycolate Oxidase (GO ) Fluorescent Assay for Glyoxylate

Standardization of the Fluorescent Glycolate Oxidase (GO) Assay with Glycolate and
Glyoxylate.

The glycolate oxidase assay consisted of a standard solution of 70mM sodium phosphate
pH 7.8, 50μM Amplex red, 0.1mM FAD, 1U/mL HRP, and either 0 – 10μM glycolate, or
0 – 10μM glyoxylate in a final volume of 300μL. Commercially available glycolate
oxidase as purchased from Sigma contains 2mM FMN. Excess FMN was removed from
the enzyme solution by dialysis against 3L of 10mM Tris-HCl pH 7.4. 0.75mM FAD
was then added to the apo-enzyme, and pre-incubated for at least 1 hour in order to be
fully catalytically competent in the glyoxylate assay. It is necessary to note that the
enzyme must be pre-incubated with the FAD cofactor prior to its use. The reaction was
initiated by the addition of glycolate oxidase (final concentration = 0.2mg/mL) and
fluorescence determined after 1 hour at 37oC for the glyoxylate substrate, and after a 20
min. incubation for the glycolate substrate.

Fluorescence produced from the Amplex

Red oxidation in the absence of glyoxylate or glycolate was subtracted from that obtained
in the presence of glyoxylate / glycolate.

86

Standardization of the Fluorescent Glycolate Oxidase (GO) Assay for PAM Produced
Glyoxylate

Glyoxylate production was initiated by the addition of PAM (0.015U/mL) to a solution
containing 40mM MES/NaOH pH 6.0, 10U/mL HRP, 1.0mM catechol, 0.5μM Cu(SO4),
20μM dansyl-Tyr-Val-Gly, the reaction proceeded for one hour at 37oC.

The PAM

dependent conversion of 20μM N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 and
glyoxylate was verified to be 100% by a RP-HPLC assay (chapter 2), to ensure a 20μM
PAM produced glyoxylate solution. Aliquots of the PAM produced glyoxylate pertaining
to variable concentrations (1.0, 3.0, 5.0, 7.0 and 9.0μM) were taken for analysis by the
glycolate oxidase assay. The aliquots of glyoxylate were added to a solution of 70mM
sodium phosphate pH 7.8, 50μM Amplex red, and HRP (1U/mL) in a final volume of
300μL. All fluorescent reactions were initiated by the addition of 0.2mg/mL GO, 0.1mM
FAD (final concentration). All samples were incubated for 1 hour at 37oC prior to
fluorescent analysis of resorufin production.
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Chemi-Luminescent Assays for Glyoxylate;

A Hydrogen Peroxide Chemi-Luminescent Standard Curve

A standard working solution of 0.1mM Luminol in 0.1M NaHCO3 pH 10.5 was prepared
and purged in an atmosphere of N2, (20 min. N2/100mL solution) and stored at 4oC in the
dark, the stock was prepared fresh daily. Black flat-bottom 96 well microplates were
prepared by the addition of 8μL HRP (11mg/mL) and 67μL of sodium bicarbonate
(0.4M), microplates were incubated for at least 45 min. in the dark prior to luminetric
analysis. A Berthold / Tropix TR-717 binary injector microplate luminometer, with a
500μL dead volume was utilized for all microplate luminescent assays. The luminometer
dead volume is defined as the volume of sample retained in-line after injection prior to
reaching the detector for measurement. The primary injector was programmed to inject
200μL of the sample (hydrogen peroxide) and the offset injector was programmed to
inject 25μL of the luminol stock. Thus, each well contained a final concentration of
0.3μg/μL HRP, 8.0μM Luminol, 0.1M NaHCO3 pH 10.5, in a final volume of 300μL.

Standard hydrogen peroxide concentrations (5nM, 7nM, 10nM, 20nM, 50nM) were
prepared within a 600μL final sample volume for luminetric analysis. Microplates were
prepared such that the injection of 200μL peroxide, 25μL luminol, in addition to the HRP
/ NaHCO3 prepared plates resulted in a final well volume of 300μL. Chemi-luminetric
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measurements (RLU = Relative Luminescence) were obtained in the flash kinetic mode,
with a 1.6sec. time delay between sample and luminol injection.

All measurements were obtained immediately following luminol injection for a time
duration of 10 seconds.

Three sequential 200μL injections of the standard were

necessary to analyze the total 600μL hydrogen peroxide sample. A water blank control
was injected prior to and in between each standard H2O2 solution in order to define a
baseline background RLU chemi-luminescent signal, for signal / noise analysis.

A

standard curve was generated from the total RLU generated per standard peroxide
solution.
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Chemi-Luminescent Glycolate Oxidase Assay with Glyoxylate

Following standardization of the chemi-luminescent dependent system for the
quantification of hydrogen peroxide, the detection system was applied to the
quantification of glyoxylate dependent H2O2 production. A standard glyoxylate solution
(7nM, 20nM, 50nM, 80nM, 200nM) was utilized to develop a standard curve for the
detection of glycolate oxidase produced hydrogen peroxide.

All glycolate oxidase

reactions were performed in 100mM phosphate buffer pH 7.8, with a final concentration
of 0.48U/mL glycolate oxidase, 0.2mM FMN in a final volume of 600μL. It was not
necessary to dialyze the FMN containing enzyme as FMN does not interfere with the
chemi-luminescent detection system.

Microplates were prepared with 8μL HRP

(11mg/mL) and 67μL of sodium bicarbonate (0.4M), incubated for one hour, prior to the
analysis of glyoxylate dependent H2O2 production. Each 600μL reaction was injected
over three wells as 200μL aliquots per well. In total, the addition of sample (200μL),
luminol (25μL), HRP (8μLl) and NaHCO3 (67 μL), resulted in a final concentration per
well of 0.3μg/μL HRP, 8.0μM luminol, 0.1M NaHCO3 pH 10.5, in a final volume of
300μL. The background RLU was determined by the addition of all reagents excluding
the glyoxylate, and the blank was injected prior to and between each standard glyoxylate
concentration. A standard curve was generated by the addition of RLU response per well
for each standard glyoxylate sample. The detection limit was defined as the signal over
background

which

fit

a

linear

regression
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of

RLU

vs.

[glyoxylate].

Chemi-luminescent Glycolate Oxidase Assay for PAM produced Glyoxylate

Preparative RP-HPLC for the Collection of the PAM substrate N-dansyl-Tyr-Val-Gly;
An Empirical Trial for the Use of the Platform Technology to Detect a GlycineExtended Peptide

A 20μM sample of the PAM substrate N-dansyl-Tyr-Val-Gly was injected onto a
Keystone ODS Hypersil C18 column (100 × 4.6 mm, 5 μ particle size) RP-HPLC column,
equipped with a Bio-Rad Model 1200 in-line fraction collector at 1.0 min intervals. The
analyte was separated and collected by an isocratic mobile phase of 100 mM sodium
acetate pH 6.0 / acetonitrile (52/48) at flow rate of 1.0mL/min [90]. Fractions were
collected over the 4 minute separation, lyophilized to dryness, and reconstituted in PAM
assay conditions consisting of 40mM MES-NaOH pH 6.3, 1mM sodium ascorbate,
0.5μM CuSO4, 10U/mL HRP, 0.015U/mL PAM in a final volume of 300μL. The PAM
reaction proceeded for 1 hour at 37oC, 10μL aliquots per fraction were removed for
percent conversion analysis of N-dansyl-Tyr-Val-Gly to N-dansyl-Tyr-Val-NH2 by the
described RP-HPLC assay [111]. Conversion of the N-dansyl-Tyr-Val-Gly substrate to
the products N-dansyl-Tyr-Val-NH2 and glyoxylate, was analyzed by a RP-HPLC PAM
activity assay (Chapter 2), to ensure 100 % conversion of the substrate in order to verify
the reaction products at [N-dansyl-Tyr-Val-NH2] = [glyoxylate] = 20μM. Following the
PAM reaction, and product analysis, an aliquot of 2U/mL of ascorbate oxidase was added
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to all PAM reactions at 40mM MES pH 6.3 to oxidize the remaining ascorbate. It was
necessary to oxidize all remaining ascorbate in the PAM reaction, as the reductive
properties of ascorbate suppress the oxidation of luminol, necessary for light production.
The resultant solution was utilized as a standard PAM produced glyoxylate stock, for use
in the glycolate oxidase assay for PAM produced glyoxylate.

Aliquots of the PAM reaction corresponding to variable concentrations of glyoxylate
(7nM, 20nM, 80nM, 200nM) were taken for analysis by the chemi-luminescent glycolate
oxidase assay. Aliquots were added to a solution containing 100mM sodium phosphate
buffer pH 7.8, reactions were initiated by the addition of 0.48U/mL glycolate oxidase,
0.2mM FMN and reacted for one hour at 37oC at a final volume of 600μL. The RLU
response per [glyoxylate] sample was analyzed as described (chapter 3).
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Results and Discussion

Resorufin Fluorescent Standard Curve

A solution of resorufin standard was prepared from a purified solid sample. A stock
concentration of 15μM was utilized to obtain the slope of 33.5RFUμM-1 (RFU = relative
fluorescent units) was obtained (Fig. 30). This value acts as an empirical standard for the
concentration dependent fluorescence of Resorufin at λex = 560nm and λem = 584nm.
Fluorescent Response of Resorufin;
λex = 560nm, λem = 584nm

90
80

y = 33.46x + 5.1914
2
R = 0.9665

Fluorescence

70
60
50
40
30
20
10
0
0

0.5

1

1.5

[Resorufin] μM

2

2.5

Figure 30. Fluorescent response of resorufin. An initial standard curve for the detection limit of
Resorufin was generated as a reference standard.
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Standardization of H2O2 Produced Fluorescence

An increase in fluorescence from the H2O2 driven HRP dependent oxidation of Amplex
Red was linear with H2O2 concentration and yielded a slope of 40.5RFUμM-1 at pH 6.0,
and a slope of 42.5RFUμM-1 at pH 7.8 (Figs. 31 & 32). Hydrogen peroxide detection
provided an value for which all enzymatic based developed assays could be compared,
and was within 17 % error of the resorufin standard.

Resorufin Standard Curve for Detection of
H2O2 at pH 6.0
Resorufin Standard Curve for Detection of Hydrogen Peroxide
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Figure 31. Resorufin standard curve for detection of H2O2 at pH 6.0. An initial standard curve for the
detection limit of hydrogen peroxide produced resorufin was generated as a reference standard at pH 6.0.
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Resorufin Standard Curve for Detection of
H2O2 at pH 7.8

Resorufin Standard Curve for Detection of Hydrogen Peroxide
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Figure 32. Resorufin Standard Curve for Detection of H2O2 at pH 7.8. Initial standard curve
developed to define the detection limit of hydrogen peroxide produced resorufin at pH 7.8.
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Glyoxal Oxidase (GLOX) Fluorescent Assay for α-Amidated Peptides

Glyoxal oxidase oxidizes the glyoxylate gem diol in the presence of O2 to produce a
stoichiometric quantity of H2O2 and oxalate (Fig. 22). Glyoxylate oxidation drives the
H2O2, HRP dependent oxidation of Amplex Red to produce an increase in fluorescence
proportional to [glyoxylate] (Fig. 31 & 32). The extinction coefficients derived from
these data are, ε = 25.8RFUμM-1 (methyl glyoxal) and ε = 12.8RFUμM-1 (glyoxylate).
The methylglyoxal slope is within 36% error of the ε value for H2O2, and within 23 %
error of the value obtained for standard resorufin. The ε value of 12.8 obtained for
glyoxylate is 3 fold reduced from the standard values. The cause for this market decrease
in sensitivity is a ramification of the significantly reduced kcat/KM value for methyl
glyoxal as compared to glyoxylate.

The efficiency of glyoxal oxidase is reduced

approximately 4-fold under glyoxylate oxidation conditions (Fig. 33). This decrease in
efficiency results in the reduced sensitivity on account of two main factors. First, the
incubation time for glyoxylate oxidation is 50 % longer as compared to methyl glyoxal,
resulting in the formation of a higher background fluorescence for the zero glyoxylate
control. Secondly, as mentioned in the introduction to chapter three, low signal to noise
is the foremost cause of sensitivity loss in fluorescent assays. Therefore, on account of
the reduced enzyme efficiency the detection limit of this assay suffers. The ultimate
detection limit for glyoxylate with this assay was 0.3 nanomoles.
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Glyoxal Oxidase Activity Standard Curve
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Figure 33. Glyoxal Oxidase Activity Standard Curve. Glyoxal oxidase activity for methyl glyoxal as
compared to glyoxylate was analyzed to determine the stoichiometric response for glyoxal oxidase
glyoxylate oxidation. The error bars represent the standard deviation of triplicate samples.

Glyoxal oxidase activity is severely inhibited in the presence of a reductants. Kurek and
Kersten [104] define catechol as a severe inhibitor of glyoxal oxidase activity, therefore
catechol could not replace ascorbate in the PAM reaction for the glyoxal oxidase
dependent glyoxylate fluorescent assay.

Furthermore, a treatment of the catechol

supported PAM reaction with catechol oxidase was tried as an avenue for the removal of
catechol. Unfortunately, the oxidized dione product is intensely dark which inhibits all
resorufin fluorescence. Several other known PAM reductants were analyzed, however
their presence also markedly hindered the ability of the glyoxal oxidase assay to detect
PAM produced glyoxylate. Recall from chapter three that glyoxal oxidase must be in the
oxidized form to support catalysis, on account of its copper radical mechanism, therefore
presence of such reductants inactivates glyoxal oxidase.
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For these reasons, it was

decided that glyoxal oxidase was not the enzyme of choice for the detection of PAM
produced glyoxylate.
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Glycolate Oxidase Fluorescent Assay for α-Amidated Peptides

Glycolate oxidase oxidizes glycolate in the presence of O2 to glyoxylate and H2O2
(chapter 2, Fig 12). The gem diol of glyoxylate an alternate substrate for glycolate
oxidase is oxidatively (stoichiometric O2 required) converted to H2O2 and oxalate
(Chapter 2, Fig. 14). Glyoxylate / glycolate oxidation drives the H2O2, HRP dependent
oxidation of Amplex Red to produce an increase in fluorescence proportional to
[glyoxylate] / [glycolate] consumed (Fig. 34). The extinction coefficients derived from
standard curve analysis are ε = 5.83RFUμM-1, (glycolate) and ε = 3.78RFUμM-1
(glyoxylate).

Standard Curve of the Glycolate Oxidase Dependent
Fluorescent Assay for Glycolate vs. Glyoxylate
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Figure 34. Standard curve of the glycolate oxidase dependent fluorescent assay for glycolate vs.
glyoxylate. Glycolate oxidase activity for glycolate as compared to glyoxylate was analyzed to determine
the stoichiometric response for glyoxal oxidase glyoxylate oxidation.
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The glycolate and glyoxylate slopes are within 36% error of the each other and
approximately 10-fold reduced for the value obtained by H2O2 Amplex Red oxidation.
Glycolate oxidase is a flavin dependent enzyme, therefore requires a minimal amount
(0.05mM) flavin prosthetic for activity.

The FAD supported catalysis for the data

presented in chapter three shows a ten fold decrease in sensitivity as a result of the
presence of FAD.

The fluorescence spectra of FAD has a λex = 450nm and a

λem = 530nm, which overlays with the fluorescent spectra of FAD (Fig. 35). The result
of fluorescence overlap is decreased sensitivity since the observed fluorescent emission
in this case is not a ‘dark’ process. The excitation/emission overlap greatly hinders the
sensitivity of this particular fluorescent assay. The two values obtained for glycolate
(ε = 5.83RFUμM-1-) and glyoxylate (ε = 3.67RFUμM-1) are within 36% error, the
difference owing to decreased enzyme efficiency for glyoxylate.

Fluorescence

FAD / Resorufin Fluorescent Spectra
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Figure 35. FAD / Resorufin fluorescent spectra. An equi-molar overlay of the fluorescent spectra of
FAD and resorufin at a λex = 530nm.
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Data obtained for the detection of PAM produced glyoxylate was linear with respect to
glyoxylate, and well within error of the reported ε value for glyoxylate (Fig.36).
Comparatively, the PAM produced glyoxylate standardization was within 14%, of that
obtained from a standard glyoxylate solution. This value relates to the effectiveness of
the proposed assay to stoichiometricly detect α-amidated/glycine-extended peptides. In
conclusion, the fluorescent glycolate oxidase assay was able to detect α-amidated peptide
production at a sensitivity of 0.3 nanomoles (0.5μM in 300μL), whereas the glyoxal
oxidase assay had considerable difficulties with detection of PAM-produced glyoxylate.

Standard Curve for the Glycolate Oxidase Dependent
Fluorescent Enzyme Assay for PAM Produced Glyoxylate
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Figure 36. Standard Curve for the glycolate oxidase dependent fluorescent enzyme assay for pAM
produced glyoxylate. Aliquots of independently quantified glyoxylate were subjected to analysis by the
glycolate oxidase assay for glyoxylate analysis..
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Chemi-Luminescent Glycolate Oxidase Dependent Assay for Glyoxylate

The H2O2 dependent HRP catalyzed luminol chemi-luminescent RLU response (RLU =
relative chemi-luminescence) was linear over a range from 10 to 80nM with respect to
[H2O2] concentration and yielded a slope of 618.2RLUnM-1 (Figs. 37 & 38). This was
within 7.0 % of the value obtained by the glycolate oxidase dependent H2O2 production
from [glyoxylate] / [d-YVG] of 574.7RLUnM-1 (Fig. 35). Chemi-luminescent standard
curve analysis of PAM produced glyoxylate was provided results comparable to
exogenous H2O2.

The RLU value deviates from linearity approaching 100nM (30

picomoles). The assay is sensitive within error to 5nM hydrogen peroxide and 15nM
[glyoxylate]. The chemi-luminescent assay has sensitivity well within the nM range (~515nM).

The microplate formatted assay has a detection limit of approximately 1.5 x 10-12moles
peroxide, 4.5 X 10-12moles glyoxylate at a final volume of 300μL. The luminescent
assay displays a marked increase in sensitivity as a result of the large difference in light
emission of luminol as compared to resorufin. Recall, that one major contributing factor
to the detection of peroxide in the fluorescence assay was the overlap of FAD and
resorufin. The red emission at 584nm of Amplex red in the fluorescent assay is affected
by the orange emission of FAD at 525nm. Luminol light emission is within the range of
λem 440-480nm. The drastic blue shift in emission markedly decreases the background
102

emission of flavin allowing for greater sensitivity.

Additionally, intrinsic protein

(enzyme) fluorescence is not an additive factor for a low signal / noise ratio chemiluminescent assays, as proteins do not intrinsically chemi-luminescence.
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Chemi-luminescent Standard Curve for Hydrogen
Peroxide
Chemi-luminescent StandardCurve for Hydrogen Peroxide
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Figure 37. Chemi-luminescent standard curve for hydrogen peroxide. Data was obtained by taking the
double integration with limits of RLU signal per time and RLU signal per well.
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Figure 38. Glycolate oxidase chemi-luminescent standard curve for PAM produced glyoxylate. The
tri-peptide dansyl-Tyr-Val-Gly was collected from a RP-HPLC separation, lyophilized, and treated with
PAM.
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Linear Detection of Chemi-Luminescence
5.5
5

R
L
U

4.5
log10 dbl Int

L
o
g

4
3.5
3
2.5
2
0

100

200

300 [H2O2] nM 400

500

600

Figure 39. Linear detection range of chemi-luminescence. A log10 plot was created in order to
determine the extent to which the observed chemi-luminescence was linear.

The glyoxal oxidase assay (data not shown) provided the least sensitive determination of
glyoxylate dependent production of peroxide. In addition to the decreased sensitivity the
enzyme is not readily available and would require the growth of wood rot fungus
(Phanaerochaete chrysosporium, [99]), as a source for enzyme purification. Therefore,
the glycolate oxidase assay was chosen as the premiere assay for peptide discovery.

In conclusion, the chemi-luminescent assay proved most sensitive of all developed
assays. Fluorescent assays are often very sensitive into the nM range (Fig. 30) of analyte.
However the flavin interference, in addition to long incubation times increasing
background fluorescence, presented a definite loss in fluorescent sensitivity.

The

luminescent assay was chosen as the premiere assay for α-amidated peptide discovery.
Luminol light emission is generally within the range of 440nm to 480nm, thus there is no
flavin interference to adversely affect the signal. Albeit, the development of three novel
105

assays for glyoxylate, not all demonstrated usefulness towards the outlined platform
technology.
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Chapter Four

Platform Technology Process

Introduction

Application of the Glyoxylate Assays to the Discovery of α-Amidated Hormones

In order to establish the feasibility of the proposed platform technology to identify novel
α-amidated peptides from cell culture, it must first be demonstrated as working prototype
for the discovery of a known α-amidated peptide accumulated from cell culture. αAmidated peptide secreting cells when grown in the presence of a PAM inhibitor,
accumulate the glycine-extended precursors (PAM substrates). Recall, from chapters 2
and 3 that each developed glyoxylate assay was applied to the detection of PAM
produced glyoxylate (from a peptide substrate) as an initial feasibility study. To further
this work, glyoxylate detection was applied to the discovery of an α-amidated/glycineextended peptide accumulated in cell culture. The detection of a known glycine-extended
peptide accumulated in cell culture, served as an empirical trial to establish the
performance of the glyoxylate assay(s) as a general tool for the detection of α-amidated
hormones.
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Utilization of the Mouse Pituitary Cell Line in the Platform Technology

A cell line known to express PAM, and an α-amidated hormone in appreciable quantities
was chosen for the cell culture empirical trial.

For this purpose a mouse neuro-

intermediate pituitary, corticotropic tumor cell line (AtT-20) known to express high
levels of PAM and mouse joining peptide (mJP-Gly; an α-amidated peptide) was chosen
as a pragmatic trial. mJP-Gly, in addition to α-MSH-Gly are the proteolytic cleavage
products of the parent peptide pro-adrenocorticotropin (ACTH/endorphin) (Fig. 37).
Following dibasic proteolytic cleavage (Lys-Arg, mJP; Lys-Lys, α-MSH) the
corresponding glycine-extended prohormones are produced [33]. Both mJP-Gly and αMSH-Gly are substrates for PAM. Mouse joining peptide (mJP) was chosen as the
peptide of interest for this study based previous data which established mJP-Gly as the
peptide in majority (Fig. 40 & 41).

α M SH

γ3M S H

S ig n a l
P ep tid e

16 K F ragm ent

m JP
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β M SH

βLPH

Figure 40. Proteolytic processing of the mouse pro-ACTH / endorphin homologue. Processing
and the respective nomenclature of each resulting peptide [113].
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Proteolytic Processing of the Mouse pro-ACTH / Endorphin
Homologue

Mains et. al [4] report an eighty percent inhibition of mJP-Gly amidation in At-T20 cells
when grown in the presence of 0.5 μM – 2.0 μM disulfiram (1,1'-dithiobis(N,Ndiethylthioformamide), a copper chelating PAM inhibitor. Disulfiram was chosen based
on previous work which demonstrated its use as a PAM inhibitor in AtT-20 cells, and the
resultant accumulation of mJP-Gly. Moreover, disulfiram is not extremely lethal to cell
growth, and is a reversible inhibitor of PAM, as the disulfiram is metabolized over time,
PAM activity is restored.
Ala-Glu-Glu-Glu-Ala-Val-Trp-Gly-Asp-Gly-Ser-Pro-Glu-Pro-Ser-Pro-Arg-Glu-Gly
Ala-Glu-Glu-Glu-Ala-Val-Trp-Gly-Asp-Gly-Ser-Pro-Glu-Pro-Ser-Pro-Arg-Glu-NH2
Figure 41. mJP Sequence. Sequences of both the glycine-extended form of mJP-Gly (19-mer) and
the PAM amidated product (18-NH2) [105].
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Utilization of the Rat Neuro-intermediate Cell Line in the Platform Technology

Rat CA-77 cells which produce glycine-extended calcitonin gene-related peptide (CGRPGly, Fig. 42) were cultured by Unigene Laboratories, Inc. As a blind analysis Unigene
Labs sent samples to USF for the verification of the presence of CGRP-Gly from a
cellular extract.

Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-SerArg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-SerGlu-Ala-Phe-Gly
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-SerArg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-SerGlu-Ala-Phe-NH2
Figure 42. CGRP Peptide Sequence. Sequence of the glycine-extended and amidated forms of the rat
thyroid CGRP peptide [114].
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Materials and Methods

Materials

Mouse pituitary AtT-20 cells, Ham’s F-12K Medium, horse serum, and bovine serum
albumin were purchased from the American Type Cell Culture Collection
(www.atcc.org).

Benzamide, MES buffer, ascorbate oxidase, and all HPLC grade

solvents were purchased from Sigma-Aldrich. All cell culture flasks (T-125, 100mm
Petri dishes) were purchased from Gibco-BRL. Disulfiram was purchased from Fluka.
Sep-Pak® Plus C18 cartridges, and an Atlantis® dC18, 4.6 x 250 mm, 5μm column was
purchased from Waters Corp. The mouse joining peptide-Gly (mJP-Gly) and mouse
joining peptide-NH2 (mJP-NH2) were synthesized in-house at the USF core peptide
synthesis and Mass Spec facility run by Dr. Ted Gauthier. CGRP-Gly was purchased
from American Peptide, Inc. PAM was a generous gift from Unigene Labs, Inc. All
other reagents and solvents were of the highest quality available.
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Methods

At-T20 Cell Growth Conditions

Mouse pituitary cells were grown in Hams F-12K® culture medium supplemented with
15% (v/v) horse serum, 2.5% (v/v) fetal bovine serum, containing 1% (v/v) of the
antimicrobial Pen-Strep (10,000 units Penicillin (Base)/mL and 10,000 μg Streptomycin
(Base)/mL in 0.85% NaCl (liquid). Cells were rapidly thawed from liquid N2, added to
fresh media and incubated in the presence of 5% CO2 at 37oC. The AtT-20 cells were
non-adherent, therefore cells were passed at a ratio of 1:3 into fresh media after 40%
confluency was reached in each culture flask.

A sterile laminar flow hood in

combination with sterile technique was utilized for all cell culture work. Cells were
grown in a 37oC incubator equipped with a constant flow of 5% CO2 to maintain cell
growth.
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At-T20 Cell Growth for the mJP-Gly Accumulation Methodology

A 2.5mM disufiram stock solution was prepared in 70% EtOH for addition to cell culture
suspensions. The AtT-20 cells were grown in T-75 cell culture flasks (≈20mL of
media+cells/flask), prior to cell harvesting for accumulation studies. A total of 5, T-75
flask cell suspensions (Vt of cells & media ≈ 100mL) were collected for disulfiram
dependent PAM inhibition. The cell suspension was collected in 15mL centrifuge tubes,
centrifuged (2,000 x g) for 3 min., and the supernatant spent media removed by
aspiration.

The centrifugation and aspiration step was repeated until all the entire

suspension was collected from the 8, T-75 culture flasks. A total of 7 centrifuge tubes
were utilized to collect all AtT-20 cells.

Seven, 100mm cell culture flasks were prepared for disulfiram inhibition by the addition
of 7mL of media containing 5μM disulfiram (16μL of 2.5mM stock). The cells were
collected from the 7 centrifuge tubes by resuspension in 1mL media, and added to the
100mm culture flasks. The final volume of each flask was 8mL media containing 5μM
disulfiram, flasks were incubated at 37oC, in a 5% CO2 atmosphere, for 20 hours. The
entire procedure was repeated for the non-disulfiram treated negative control cells, with
substitution of simply the 70% EtOH carrier for disulfiram.
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Extraction of mJP-Gly from At-T20 Cells

Cells were collected by centrifugation, the supernatant spent media was decanted and
acidified to 0.1% (v/v) TFA with a 6% TFA stock (1.6 mL 6% TFA added to 100 mL).
Whole cells were homogenized at 4ْ C in a ground glass homogenizer with an acid extract
containing 0.1M HCl, 5% (v/v) formic acid, 1% (w/v) NaCl, 1% (v/v) TFA [4]. The
homogenate was centrifuged, the supernatant collected and added to the acidified media.
The remaining cell pellet was again homogenized, centrifuged, and the supernatant added
to the acidified media. The solution was approximately 125mL of 0.1% TFA spent
media including the homogenized extract. The same procedure was followed for the nontreated cells.
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Purification of Cellular Extract on a Sep-Pak® Plus Cartridge

The acid extract was initially purified by solid phase extraction on a Waters Sep-Pak®
Plus cartridge prior to HPLC separation. This initial step served to both de-salt and
concentrate the spent media/cellular extract containing the accumulated glycine-extended
peptides.

A 5mL syringe was used to load the Sep-Pak®Plus cartridge with 5mL of a

column pre-wetting solution composed of 0.1%(v/v) TFA/80% Acetonitrile at a flow rate
≤ 2.0mL/min. The cartridge was then rinsed with an aqueous solution of 0.1 % (v/v)
TFA at a flow rate of 5.0mL/min. The entire spent media/cell extract (Vt = 125mL) was
loaded onto the cartridge at a rate of 3.0mL/min, followed by a wash of 20mL of 0.1%
TFA (v/v). Elution of the desired peptide mixture was accomplished by the addition of
3mL of 0.1% (v/v) TFA/80% at a flow rate ≤ 0.5mL/min. The 3mL eluent was collected
and lyophilized on a Savant SpeedVac® concentrator equipped with a Savant VLP 120
Vaccuum pump, then resuspended in 250μL of 0.1% TFA (v/v)/0.001 % Triton-X for
injection on the HPLC.
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Preparation of the Cellular Extract for HPLC Purification

The entire 250μL portion of the resuspended cellular extract was divided into four
separate samples for further analysis. Two of the four samples were purely experimental
for the analysis of mJP-Gly accumulation by PAM inhibition in cell culture, by both
MALDI-TOF and glyoxylate analysis (samples A and B). The remaining two were
prepared as spiked standards and 2.5 nmoles of the standard mJP-Gly was added to the
60ul aliquot prior to HPLC separation (samples C and D). For experimental purposes
samples were denoted as A-D which corresponded to the sample injected onto the HPLC
and 1-70 to indicate fraction number. To exclude any cross contamination or analyte
carry-over, the non-spiked cell extract samples A and B were injected and separated prior
to the injection of spiked samples C and D.
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RP-HPLC Separation of the Accumulated mJP-Gly

A quaternary solvent delivery HP-1100 LC unit equipped with a autosampler /
autoinjector, a heated column compartment, and a ChemStation software package was
utilized to perform a binary linear gradient separation of 100% 0.1 % TFA to 52 %
acetonitrile over the duration of sixty-five minutes. A flow rate of 1.0mL/min at a
detection λ of 278nm at 37oC was utilized to define the standard retention time and signal
of pure mJP-Gly. An initial RP-HPLC standard curve was performed on an mJP-Gly
standard as a control for the confirmation of analyte retention time and signal.
Additionally, RP-HPLC of an equimolar mixture of mJP-Gly and mJP-NH2, verified that
both the amidated and glycine extended forms co-elute as stated by Mains et. al. [4].

A 60μL sample injection volume (Vt = 65μL for internal standard samples C and D) of
the crude AtT-20 peptide extracts was loaded onto a Atlantis® dC18, 4.6 x 250mm, 5μm,
reverse phase analytical HPLC column. A Bio-Rad 1200 fraction collector was set inline to collect HPLC fractions at the time interval of 1.0mL / min and was operator
controlled.

To avoid any HPLC sample carry over spiked fractions containing

2.5nanomoles mJP-Gly internal standard were analyzed after accumulated samples.
Following HPLC fraction collection all fractions were lyophilized to complete dryness on
a Savant Speed Vac® concentrator equipped with a Savant VLP 120 vacuum pump and
stored at -80oC. It must be noted that no true qualitative and/or quantitative analysis of
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mJP-Gly accumulation can be made based solely on the results of the RP-HPLC
separation data, and therefore RP-HPLC was solely a preparative method.
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Definition of Collected Sample Content for mJP-Gly Characterization

For the initial characterization of mJP-Gly accumulation in cell culture samples, a
duplicate set of samples were prepared and analyzed by two independent methods. As
previously described samples were designated A through D to inform of the contents, for
example non-spiked (A, B) and spiked (C, D). For notation purposes a subscript number
following the letter informs of the trial number, and a regular font sized number records
the fraction number. For example, A2-35 defines the sample as non-spiked, trial 2,
fraction number thirty-five. Fraction sample sets were split, each set to be designated as
glyoxylate analysis (odd numbers A1,3,5 through D1,3,5) or MALDI-TOF analysis (even
numbers A2,4,6 through D2,4,6) (see Table 5.). A total of samples A1-6 through D1-6 were
analyzed by both methodologies, for a total of three sets of glyoxylate vs. mJP-Gly
analysis. Initially, samples A1-D1 were characterized by the methods of the newly
developed platform technology for the verification of mJP-Gly via glyoxylate detection.
Thus, the duplicate sample sets A2 - D2 demonstrated inhibition of PAM in cell culture
via MALDI-TOF analysis for the presence of the mJP-Gly. After detection of glyoxylate
in samples A1 - D1, and mJP-Gly in samples A2 - D2, duplicate sets were then analyzed.
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Definition of Platform Technology
Sample Notation

Sample Name

Analyte Detected

Method of Detection

A1; 1 -70

Accumulated mJP-Gly/glyoxylate

Chemi-luminescence

B1; 1 - 70

Accumulated mJP-Gly/glyoxylate

Chemi-luminescence

C1; 1 - 70

Spiked mJP-Gly/glyoxylate

Chemi-luminescence

D1; 1 - 70

Spiked mJP-Gly/glyoxylate

Chemi-luminescence

A2; 1 - 70

Accumulated mJP-Gly

MALDI-TOF Mass Spec

B2; 1 - 70

Accumulated mJP-Gly

MALDI-TOF Mass Spec

C2; 1 - 70

Spiked mJP-Gly

MALDI-TOF Mass Spec

D2; 1 - 70

Spiked mJP-Gly

MALDI-TOF Mass Spec

Table 5.
Definition of platform technology sample notation. Samples were defined by analyte, detection method,
and fraction number. A designated notation was necessary to keep the large sample numbers organized.
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Treatment of RP-HPLC Fractions with PAM; Production of mJP-NH2/Glyoxylate

Fractions 26 through 35 from samples A1;26-35 through D1; 26-35, were treated with
PAM. Lyophilized samples were resuspended in 100μL, of a PAM reaction mixture
containing 40 mM MES buffer pH 6.3, 1.0mM sodium ascorbate, 0.5μM CuSO4,
10U/mL HRP, and 0.1 mg PAM, and reacted in a 37oC water bath overnight. An aliquot
of 2U/mL ascorbate oxidase was added, and the reaction incubated for 1 hour at 37oC.

Analysis of mJP-Gly Dependent Glyoxylate Production by Chemi-luminescence

Fractions 26 – 35 of sample set A1 through D1 were brought up to 600μL in glycolate
oxidase reaction conditions. The pH was verified as pH 7.8, and samples were tested for
glyoxylate utilizing the newly developed chemi-luminescent glyoxylate assay (chapter 3).
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Matrix Assisted Laser Desorption Ionization – Time of Flight Mass Spectrometry
Analysis for mJP-Gly Accumulation

Fractions 26 – 35 of sample set A2 through D2 were removed from storage at -80oC and
resuspended in 20μL of 0.01% (v/v) TFA for Mass Spec analysis. A matrix of α-cyano4-hydroxy-cinnamic acid was spotted in a 1:1 ratio of matrix : analyte on a 384 carbon
plate and evaporated to dryness to allow for complete sample : matrix co-crystallization.
A MALDI-TOF equipped with an N2 laser of 337nm was operated in the positive ion
analysis mode, utilizing an acceleration velocity of 19.00kV at the initial ion source, a
130nanosecond time delay, and a second ion source at the extraction plate of 16.35kV.
All MALDI-TOF data was collected from the reflector detector and calibrations were
performed externally with a standard peptide mixture.
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Demonstration of the Platform Technology by a Blind Experiment; Analysis of
Peptide-Gly Samples Sent by Unigene Laboratories, Inc.

Unigene Cell Growth Conditions

Rat CA-77 cells which produce CGRP-Gly were grown in T75 flasks to 60 – 90%
confluency in DMEM:F10 media (supplemented with insulin, transferrin and selenium)
and 10% fetal bovine serum (FBS). Cells were collected and washed twice with PBS to
remove residual serum/media.

The cells were then grown in serum free media

(DMEM:F10) supplemented with transferrin and selenium for either 24 or 48 hours under
accumulation conditions. 0.1μM of the dexamethasone secretagogue and, 100μM of
diethyldithiocarbamic acid a PAM inhibitor were added to the media for the
accumulation of CGRP-Gly. Insulin, present at high concentration in the medium, was
omitted from the accumulation growth medium to avoid potential interference during
purification. Conditioned medium was harvested and cellular debris was removed by
centrifugation.
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Unigene Extraction of CGRP-Gly From Rat CA-77 Cells

Approximately 270mL the conditioned medium was loaded onto a Bio-Cad Sprint
Perfusion LC System equipped with an Amberchrom CG300M column (1.1cm x 14.5cm)
equilibrated with 0.1% TFA (v/v) / 2% acetonitrile. After sample loading the column was
washed with 1% (v/v) TFA / 10% acetonitrile to remove cell culture by-products. The
absorbance was monitored at 220nm, with a flow rate of 27Ml / min. Peptides were
eluted with a mobile phase containing 0.1% TFA (v/v) / 50% acetonitrile and the
resultant peak, which had previously been shown to contain the majority of the peptides
in the conditioned medium, was collected.

The peptide fraction was concentrated

approximately 10-fold by lyophilization, and acetonitrile was added to a final
concentration to ≈ 5%. All particulate matter following the acetonitrile addition was
removed by centrifugation.
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Unigene Purification of Rat CGRP-Gly by RP-HPLC

The concentrated peptide fraction was loaded onto a Rainin HPLX, HPLC equipped with
a Hypersil BDS C18 column (4.6mm x 250mm) equilibrated with 0.1% (v/v) TFA / 20%
acetonitrile, and set in-line to an LKB Bromma Model 2112 Redifrac fraction collector.
The column was initially washed with 0.1% TFA (v/v) / 20% acetonitrile for 18 minutes.
Peptides were eluted with a linear gradient from 0.1% TFA (v/v) / 20% acetonitrile to
0.1% TFA (v/v) / 52% MeCN over a duration of 60minutes. The column was operated at
1.2mL / min, and the effluent monitored at an absorbance of 220nm by an Applied
Biosystems model 683 programmable spectrophotometric detector.

Approximately

1.5mL fractions were collected over 60 minutes. Fractions 15 through 41 (fraction set
# 1) were collected and concentrated to dryness by lyophilization, and sent to the
University of South Florida for CGRP-Gly analysis. The retention time of CGRP-Gly
was determined by the injection of a pure CGRP-Gly standard. Duplicate fraction sets #
1- 3 were prepared by the described methodology.
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Analysis of Unigene Fractions for CGRP-Gly by the Developed Platform Technology

Unigene fractions 20-29 from fraction set # 1 were selected to undergo the described
platform technology.

The fractions were resuspended in 100μl of PAM reaction

conditions, 40mM MES pH 6.3, 1.0mM sodium ascorbate, 0.5mM CuSO4, 10U/mL
HRP, and 0.015U/mL PAM. The PAM reaction conditions for CGRP-Gly amidation
were specified by Unigene Laboratories, Inc. The reaction proceeded for 1 hour at 37oC,
and was followed by a 1 hour incubation with 2U/mL of ascorbate oxidase. The samples
were brought to 600μL in 100mM Phosphate Buffer pH 7.8, and analyzed by the
developed chemi-luminescent assay for glyoxylate.

The platform technology was

repeated on fractions 18 – 34 from fraction set #1, and fractions 27 – 32 of fraction set
# 3.
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Matrix Assisted Laser Desorption Ionization – Time of Flight Mass Spectrometry
Analysis for CGRP-Gly Accumulation

Fractions 20 – 31 of fraction set # 2 were sent from Unigene Laboratories, Inc. for Mass
Spectral Analysis of CGRP-Gly. A standard CGRP-Gly (American Peptide, Inc.) was
initially analyzed to establish the CGRP-Gly parent ion (m/z), by the described methods
(chapter 4). Fractions 27-32 were resuspended in 10μL of 0.1% (v/v) TFA, and spotted
in a 1 : 1 ratio (matrix : analyte) on a 384 carbon plate and evaporated to dryness. The
MALDI-TOF procedure for fraction analysis was performed as described (chapter 4).
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Results and Discussion

Demonstration of the Platform Technology to Identify mJP-Gly Accumulation by the
Inhibition of PAM in Cell Culture

RP-HPLC of the mJP-Gly Standard

Injection of standard mJP-Gly resulted in an average Rt of 31.42 ± 0.0564. The average
Rt and standard deviation was calculated over a total of 21 injections (Fig. 43).
Standard Curve for the Absorbance at 278nm of mJP-Gly as
Analyzed by RP- HPLC; mJP-Gly Rt = 31.417 +/- 0.0564
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Figure 43. Standard curve for the absorbance at 278nm of mJP-Gly as analyzed by RP-HPLC..
Standard curve anlaysis of mJP-Gly resulted in the determination of the average Rt and RP-HPLC
sensitivity of the standard peptide.
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RP-HPLC Separation of the Accumulated and Spiked mJP-Gly from At-T20 Cell
Culture

The mJP-Gly and mJP-NH2 standards, confirmed that both the mJP-Gly and mJP-NH2
co-elute in the described separation. Thus, both the mJP-Gly MW = 1999g/mol, and mJPNH2 = 1941g/mol, appear in the same HPLC fraction by Mass Spectral analysis (Fig. 50).
Moreover, RP-HPLC coupled to spectrophotometric detection is not a technique sensitive
enough to detect and quantify the accumulated mJP-Gly peptide within the linear
detection range of mJP-Gly peptide (Fig. 43).
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Analysis of mJP-Gly Dependent Glyoxylate Production by Chemi-luminescence
Fractions 29-32 of A1,3,5 and B1,3,5 show a positive luminescent signal for fractions 30 and
31.

Although results were not stoichiometricly quantifiable, the signal of mJP-Gly

accumulation is relative to (Figs. 44, 46 &. 45, 47). The chemi-luminescent signals
define fractions 30 and 31 positive for glyoxylate: mJP-Gly in both accumulated and
spiked samples. These fraction numbers are within standard deviation of the RP-HPLC
Rt of mJP-Gly as determined by standard analysis, the non-disulfiram treated cell extract
displayed no positive luminescent signal for fractions 29 -32.

Chemi-luminescent Analysis of Accumulated mJP-Gly
from At-T20 Cells
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Figure 44. Chemi-luminescent analysis of accumulated mJP-Gly from At-T20 cells. Fractions 29 – 32
were analyzed by the described method for glyoxylate dependent peroxide production. A blank solution
containing all necessary enzymes and cofactors was analyzed between fractions to establish the
luminescent baseline signal.
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Chemi-luminescent Analysis of Spiked
mJP-Gly from At-T20 Cells
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Figure 45. Chemi-luminescent Analysis of Spiked mJP-Gly from At-T20 Cells. Fractions 29 – 32
were analyzed by the described method for glyoxylate dependent peroxide production. A blank solution
containing all necessary enzymes and cofactors was analyzed between fractions to establish the
luminescent baseline signal.
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Chemi-luminescent Analysis of Accumulated mJP-Gly from At-T20
Cells
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Figure 46. Chemi-luminescent Analysis of Accumulated mJP-Gly from At-T20 Cells Fractions were
analyzed by the described method for glyoxylate dependent peroxide production. Values represent RLU
minus the average blank value obtained between samples.

Chemi-luminescent Analysis of Spiked mJP-Gly from At-T20 Cells
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Figure 47. Chemi-luminescent analysis of spiked mJP-Gly from At-T20 cells. Fractions were analyzed
by the described method for glyoxylate dependent peroxide production. Values represent RLU minus the
average blank value obtained between samples.
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Summary of Spiked vs. Non-Spiked
Cellular Extract for mJP-Gly
Fraction #

Spiked

Non-spiked

29

0

20811

30

767759

177711

31

68905

72778

32

74788

0

Table 6. Summary of spiked vs. non-spiked cellular extract for mJP-Gly. Values are obtained from
the total RLU gained minus the average blank value from each fraction analyzed for glyoxylate:H2O2
content.

The luminescent data demonstrates an approximate 4-fold increase in mJP-Gly in the
spiked extract.

Thus, the approximate amount of mJP-Gly accumulated is 0.625

nanomoles as compared to the 2.5nanomole spike.
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MALDI-TOF Analysis of Standard mJP-Gly and mJP-NH2

Mass Spectral analysis of the purified standards defined the absolute m/z values for mJPGly and mJP-NH2. Amidation of mJP-Gly results in a total mass loss of 59 [C2 H3O2]
from the glycine extended peptide. The amidated product gains one proton on the
terminal α-amine during catalysis, resulting in a true difference of 58 mass units between
the glycine-extended and amidated forms of mJP-Gly. Respectively, the m/z value for
mJP-Gly is 1999 and 1941 for α-amidated mJP-Gly (Figs. 48, 49).
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Figure 48. Mouse joining peptide precursor. MALDI-TOF of a standard mJP-Gly sample,
depending on calibration standards the parent ion is found 1998 ≥ m/z ≤ 2001.
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Figure 49. Mouse joining peptide. MALDI-TOF of a standard mJP-NH2 sample, depending
on calibration standards the parent ion is found 1940 ≥ m/z ≤ 1942.
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MALDI-TOF Analysis of Accumulated and Spiked mJP-Gly

Based on the HPLC co-elution of mJP-Gly/mJP-NH2 and incomplete PAM inhibition
both parent ions (mJP-Gly, mJP-NH2) are present by MALDI-TOF within the same
fraction (Figs. 50-52). MALDI-TOF is not a quantitative methodology based on several
variables which affect the signal of a given analyte. These variables include, matrix
composition, matrix : analyte co-crystallization, and sample ionization. Other parent ions
evident within the analyzed fractions are result of incomplete purity of cellular fractions
and most likely are remnants of the cell culture media / serum. Although the identity of
these other molecules is not known, their existence is not harmful as it is evident that they
do not interfere with the platform technology. Likewise, the existence of other peaks is
expected, and will vary among cell lines, and culture mediums used for cell growth.
MALDI-TOF analysis demonstrates the disulfiram dependent inhibition of PAM in cell
culture and thereby further validates the developed platform technology.
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Figure 50. MALDI-TOF of accumulated mJP-Gly. MJP-Gly accumulated in sample B230, accumulated mJP-Gly was found in samples B2 30 – 31.
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Figure 51. MALDI-TOF of spiked mJP-Gly. MJP-Gly from spiked sample D2-30,
samples D2 30 - 32 were positive for mJP-Gly.
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Figure 52. MALDI-TOF of accumulated vs. spiked mJP-Gly. (A) An example of MALDI-TOF data
from accumulated sample set A4 – 31, and (B) spiked sample D4 - 31 displaying the isotopic resolution
of mJP-Gly within the spiked sample.
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Demonstration of the Platform Technology to Identify CGRP-Gly Accumulation by the
Inhibition of PAM in Cell Culture

Analysis of Unigene Fractions for CGRP-Gly by Chemi-luminescence

Fractions 20-29 of Unigene sample set #1 were analyzed by the described chemiluminescent assay for glyoxylate and displayed a positive signal for rat CGRP-Gly in
fraction 29 (Fig. 53). Repeat analysis on sample set #1 of fractions 18-34, also defined
fraction 29 as positive for glyoxylate (data not shown).
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Figure 53. Chemi-luminescent analysis of Unigene fraction set # 1 for CGRP-Gly. Luminescent
analysis defines sample 29 as positive for glyoxylate.
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Analysis of Unigene CGRP-Gly Standard by the MALDI-TOF

A rat CGRP-Gly standard was supplied by Unigene for analysis of the CGRP-Gly parent
ion. The parent ion at m/z of 3860 corresponds to the standard molecular weight of rat
CGRP- (Fig. 54).
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Figure 54. MALDI-TOF of standard CGRP-Gly. The CGRP-Gly standard supplied by Unigene had a
m/z of 3860, this value corresponds to the calculated molecular weight.
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Analysis of Unigene Fractions for CGRP-Gly by the MALDI-TOF

Fractions 21-32 of Unigene fraction set #2 analyzed by MALDI-TOF displayed the
parent ion of 3860 m/z (Fig. 55).
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Figure 55. Fraction 29. Fraction 29 from the Unigene fraction set #2. Analysis of
fractions 21 -32 displays the presence of CGRP-Gly (m/z 3860) accumulated from cell
culture.
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Conclusion

The cellular accumulation of the glycine-extended peptides is the premise on which this
newly designed platform resides, without the accumulation of the glycine-extended
peptides detection of PAM produced glyoxylate is futile. The production of glyoxylate
upon treatment of cellular fractions with PAM is compelling for the accumulation of the
glycine-extended peptides but not definitive.

Mass spectral analysis of glyoxylate

positive fractions for the presence of the glycine-extended peptides provides not only
verification of the glyoxylate signal, but also it defines the framework for platform
technology. The utilization of PAM presents a novel method for the discovery of αamidated peptides.

This method relies on the ability to detect glyoxylate, a

stoichiometric product of the PAM dependent amidation of glycine-extended peptides.
This platform technology has been thoroughly optimized towards the design of both
specific and sensitive assays for glyoxylate.

This body of work has described the development of seven novel spectroscopic enzyme
based assays for glyoxylate. Detection of glyoxylate is not only useful as a PAM assay,
but is also useful in a clinical setting. The presence of glyoxylate in urine is used a
marker for monitoring kidney stone formation. To date, many of the prior glyoxylate
assays have been developed for this use, or for detection of ureidoglycolate activity
(chapter 1).
143

Each novel glyoxylate assay can also be used for the detection of PAM-produced
glyoxylate, moreover the chemi-luminescent assay has proven itself most useful for the
identification of glycine-extended peptides.

The development of this new platform

technology has proven useful as a ‘proof of concept”, as this technology has been
successful at identification of model glycine-extended peptides accumulated from cell
culture. The platform technology is now poised to be efficacious for the identification of
novel glycine-extended peptides accumulated from cell culture. Although work remains
to be done as different cell lines may require alternate PAM inhibitors, and identification
of a novel peptides will undoubtedly be difficult, an efficient and robust platform
technology for glycine-extended peptide discovery has been developed.
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Future Work for Novel Peptide Identification and Characterization

The platform technology is now poised for novel peptide discovery from a variety of
sources. Future work relies on the choice of source material, namely cell line choice.
Classically, hormones are chemical messengers which carry messages from one cell to
another. By definition, this does not imply that both PAM and an α-amidated hormone
are both synthesized in the same tissue, (cell source) which ultimately means that the cell
lines used in the platform technology do not have to express PAM.

However, as

mentioned in chapter two, PAM has been linked to both exocrine and autocrine growth
loops. This feature imparts a unique decision making option to cell line choice for the
platform technology; cells which do express PAM and cells which do not express PAM
may both be logical choices.

One definite aspect of future work lies in the process for discovery of a novel peptide.
The putative peptide must initially be purified to near homogeneity by a variety of
chromatographic techniques including reverse-phase and ion-exchange chromatography,
coupled to analytical HPLC for purity assessment.

It is possible that the platform

technology may find a glycine-extended protein fragment, although this is not likely as
there are no known endoproteases which cleave at the C-terminal side of glycine. A
variety of techniques when employed in tandem will easily dissolve any issues
concerning the identity of all novel peptides discovered by this platform technology.
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Initially, it is most important to determine the peptide sequence, a goal easily achieved by
a variety of techniques, including N-terminal sequence analysis (Edman degradation) or
LC-MS-MS. Alternatively, if Edman degradation fails sequences data can be obtained by
enzymatic C-terminal sequencing in conjunction with amino acid analysis. Sequence
data will provide the initial information to discover if in fact peptides are novel, screening
peptide databases with the putative novel peptide sequence will discover if this peptide is
simply a fragment of a larger known peptide and/or protein, and if this peptide is an
already documented α-amidated peptide.

Often, peptides are classed into families

because they exist together in one reading frame (e.g. mJP-Gly of the mouse pro-ACTH
homologue fig. 40). It is likely that a putative peptide may be contained within an open
reading frame known to contain other peptide hormones. One key feature of all the αamidated peptides is the proteolytic pathway to their formation. Recall, from chapter 1
that all peptides which ultimately become glycine-extended undergo a series of sequence
specific proteolytic events. The signature sequence for all peptides to become glycineextended is a pair of dibasic amino acids flanking the internal glycine. This hallmark of
α-amidation will most definitely provide useful information as to if the discovered
peptide hormones; are indeed truly novel α-amidated hormones. In conclusion, there are
three main factors which must be defined for identification of newly discovered peptides;
if the sequence has the correct proteolytic processing sites, is entirely contained within
one open reading frame, and contains a C-terminal glycine.

Defining the identity newly discovered α−amidated hormones may prove trivial as
compared to in vitro characterization of the newly discovered peptide. It will most likely
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require a great deal of metabolic and genomic studies to define physiological the role of
any newly discovered peptide. The peptide will need to be produced in large enough
quantities for bio-characterization, a goal accomplished by recombinant overexpression
of the peptide/peptides in E. coli.

Parameters such as tissue distribution, disease

relevance, and bio-characterization will require time, and will most likely differ among
newly discovered peptides. Northern blot analysis can provide valuable information as to
the population of peptide transcripts within a specific tissue, and aid in gathering
information as to the population in various disease states. Gene knockout and or siRNA
can also provide information as to the phenotypical and/or metabolic role of the novel
peptide in cell culture or animal studies. Several tools for the in vitro characterization of
the newly discovered peptide exist, and many can be develop as information of the
peptides role unfolds during initial studies. The use of this assay in time may lead to the
discovery of many novel peptides essential to the study of α-amidated hormones and
their physiological role. Moreover, peptides are the chemical messengers that keep living
systems in a homeostatis and abnormalities arising from their over/under production
leads to the onset of hormone induced diseases (Table 2). A platform technology for the
discovery of novel α-amidated peptides is currently in place, and the ramifications of this
technique will provide the scientific community with the basic the knowledge to pioneer
the biochemistry of novel α-amidated hormones.
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Appendix A: Abbreviations
CGRP-Gly – calcitonin gene related peptide
Dansyl - 5-dimethylamino-naphthalene-1-sulfonyl chloride
DMAB - 3-(dimethylamino)benzoic acid
GLOX – glyoxal oxidase
GO – glycolate oxidase
GR – glyoxylate reductase
HRP – horse radish peroxidase
Luminol - 3-aminophthalhydrazide
MALDI-TOF MS – matrix assisted laser deionization – time of flight mass spectrometry
MBTH - 3-methyl-2-benzothiazolinone hydrazone
mJP-Gly – mouse joining peptide
MOPS - 3-(N-morpholino)-propanesulfonic acid
MS - malate synthase
MD - malate dehydrogenase
MS / MD Assay – malate synthase / malate dehydrogenase assay
MTS - 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxylphenyl)-2-(4-sulfophenyl)2H-tetraolium, inner salt
NAD+/NADH - nicotinomide adenine dinucleotide/nicotinamide adenine dinucleotide
reduced form
PAM – peptiylglycine α-amidating monooxygenase
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PMS - phenazine methosulfate
RFU – relatice fluorescent units
RLU – relative chemi-luminescent units
RP-HPLC – reverse phase high performance liquid chromatography
TEA - triethanolamine
TFA - trifluoroacetic acid
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